{"gene":"INSM1","run_date":"2026-06-10T01:55:23","timeline":{"discoveries":[{"year":1992,"finding":"IA-1/INSM1 encodes a 510 amino acid protein with five C2H2 zinc-finger DNA-binding motifs in the C-terminal domain (aa 251-510) and a putative prohormone domain with dibasic conversion sites in the N-terminal domain (aa 1-250), establishing its basic domain architecture.","method":"cDNA cloning, sequence analysis, structural domain prediction","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 1 / Strong — original cloning paper with full sequence analysis and domain mapping, foundational result replicated across subsequent studies","pmids":["1634555"],"is_preprint":false},{"year":1994,"finding":"The IA-1/INSM1 gene is intronless; both cDNA and genomic DNA yielded identical ~61 kDa protein products in in vitro translation, and the gene was chromosomally localized to the short arm of human chromosome 20.","method":"Genomic cloning, restriction mapping, sequencing, in vitro translation, in situ hybridization","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 1 / Strong — direct experimental demonstration with in vitro translation and genomic sequencing, foundational structural characterization","pmids":["8188699"],"is_preprint":false},{"year":2002,"finding":"INSM1/IA-1 functions as a transcriptional repressor; the repressor activity resides predominantly in amino acids 168–263. Using SELEX with bacterially expressed GST-IA-1DBD, the consensus DNA-binding sequence was identified as TG/TC/TC/TT/AGGGGG/TCG/A, and zinc fingers 2 and 3 are sufficient for transcriptional activity. INSM1 can auto-regulate its own promoter and repress the NeuroD/beta2 promoter.","method":"GAL4-DBD fusion reporter assays, SELEX/random oligonucleotide binding, GST pulldown, co-transfection reporter assays, mutagenesis","journal":"Nucleic acids research","confidence":"High","confidence_rationale":"Tier 1 / Strong — multiple orthogonal methods (SELEX, mutagenesis, reporter assays) in a single rigorous study establishing repressor function and consensus binding site","pmids":["11842116"],"is_preprint":false},{"year":2002,"finding":"INSM1 protein localizes exclusively to the nucleus when expressed in transfected cells. INSM1 interacts with Cbl-associated protein (CAP); this interaction was confirmed by yeast two-hybrid, in vitro pulldown, nuclear co-localization, and co-immunoprecipitation, with both proteins detected in the nucleus of insulinoma cells.","method":"GFP-INSM1 transfection/fluorescence microscopy, yeast two-hybrid screen, in vitro pulldown, co-immunoprecipitation","journal":"Genomics","confidence":"High","confidence_rationale":"Tier 2 / Moderate — reciprocal Co-IP and multiple orthogonal methods confirming INSM1-CAP interaction and nuclear localization","pmids":["12079283"],"is_preprint":false},{"year":2003,"finding":"The NeuroD1/E47 heterodimer directly binds the proximal E-box (E3) element of the IA-1 promoter and activates IA-1 transcription; the E3 box (−426 to −65 bp region) is critical for tissue-specific promoter activity.","method":"Promoter deletion reporter constructs, EMSA, transient transfection, mutagenesis","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 1 / Strong — EMSA plus mutagenesis plus reporter assays defining the critical cis-element and trans-activating complex","pmids":["12890672"],"is_preprint":false},{"year":2006,"finding":"INSM1 functions as a transcriptional repressor of the NeuroD/beta2 gene by recruiting cyclin D1 and histone deacetylases (HDAC-1 and HDAC-3). Cyclin D1 was identified as an INSM1-interacting protein via yeast two-hybrid from a human fetal brain library; the interaction was confirmed by in vitro and in vivo pulldown. INSM1 forms a complex with cyclin D1 and HDAC-3 on the NeuroD/beta2 promoter, as confirmed by chromatin immunoprecipitation.","method":"Yeast two-hybrid, in vitro pulldown, co-immunoprecipitation, chromatin immunoprecipitation (ChIP), reporter gene assays","journal":"The Biochemical journal","confidence":"High","confidence_rationale":"Tier 1-2 / Strong — multiple orthogonal methods (yeast two-hybrid, Co-IP, ChIP, reporter assays) establishing the INSM1–cyclin D1–HDAC repressor complex","pmids":["16569215"],"is_preprint":false},{"year":2006,"finding":"Insm1 is essential for the development of pancreatic beta cells and intestinal endocrine cells. In Insm1 mutant mice, endocrine precursors form but fail to differentiate into hormone-positive cells; many genes encoding secretory machinery proteins are down-regulated. Insm1 thus controls a gene expression program comprising hormones and proteins of the secretory machinery.","method":"Insm1 knockout mouse, histology, immunohistochemistry, gene expression analysis","journal":"Genes & development","confidence":"High","confidence_rationale":"Tier 2 / Strong — genetic loss-of-function in mice with defined cellular phenotype and gene expression readout, widely replicated","pmids":["16951258"],"is_preprint":false},{"year":2006,"finding":"IA1/INSM1 is a direct transcriptional target of Ngn3 in the embryonic pancreas. Ngn3 binds to chromatin at the IA1 promoter region and activates IA1 transcription. IA1 expression is absent in Ngn3-null embryos but is normal in embryos mutant for NeuroD1, Arx, Pax4, and Pax6 (factors downstream of Ngn3), placing IA1 immediately downstream of Ngn3 in the endocrinogenic transcription factor network.","method":"Chromatin immunoprecipitation, ectopic expression in adult pancreatic duct cells, mouse mutant analysis (epistasis)","journal":"The EMBO journal","confidence":"High","confidence_rationale":"Tier 1-2 / Strong — ChIP demonstrating direct Ngn3 binding, confirmed by epistasis in multiple mutant backgrounds","pmids":["16511571"],"is_preprint":false},{"year":2007,"finding":"Neurogenin 3 (Ngn3) and its co-activator CBP occupy the INSM1 promoter, leading to hyper-acetylation of histone H3/H4 in the INSM1 promoter region; adenoviral Ngn3 induces endogenous INSM1 expression in pancreatic ductal cells through CBP recruitment.","method":"Chromatin immunoprecipitation (ChIP) for endogenous Ngn3 and CBP at INSM1 promoter, adenoviral overexpression, histone acetylation assay","journal":"FEBS letters","confidence":"High","confidence_rationale":"Tier 1-2 / Strong — direct ChIP evidence for CBP co-activator recruitment and histone acetylation at the INSM1 locus","pmids":["17300785"],"is_preprint":false},{"year":2007,"finding":"Insm1 is an essential component of the transcriptional network controlling sympatho-adrenal lineage differentiation. In Insm1 mutant mice, differentiation of sympatho-adrenal precursors is delayed, accompanied by reduced proliferation; terminal differentiation of adrenal chromaffin cells is blocked. The transcription factors Mash1, Phox2a, Gata3, and Hand2 show deregulated expression in Insm1 mutants, indicating Insm1 acts downstream of Mash1 (Ascl1) in this network. Fetal lethality of Insm1 mutants is caused by catecholamine deficiency.","method":"Insm1 knockout mouse, gene expression analysis, epistasis/genetic interaction analysis","journal":"Development (Cambridge, England)","confidence":"High","confidence_rationale":"Tier 2 / Strong — genetic loss-of-function with epistatic placement in transcriptional network, defined lethality mechanism","pmids":["18094025"],"is_preprint":false},{"year":2008,"finding":"INSM1 protein is expressed exclusively in the nuclei of late neuronal progenitors and nascent (but not mature) neurons throughout embryonic and adult neurogenesis; non-surface (basal/subventricular zone) progenitors express INSM1, whereas apically mitotic progenitors do not, paralleling the role of the C. elegans ortholog EGL-46 in terminal neurogenic divisions.","method":"In situ hybridization combined with immunohistochemistry in mouse and human embryos; cellular localization across multiple neurogenic regions","journal":"The Journal of comparative neurology","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — direct localization experiments with functional inference; single study","pmids":["18205207"],"is_preprint":false},{"year":2008,"finding":"INSM1 binds a specific site in the proximal insulin promoter and represses insulin gene transcription by approximately 50%. Repression is mediated by recruitment of cyclin D1 and HDAC-3 to the insulin promoter. ChIP in beta TC-1 cells, mouse fetal pancreas, and Ad-INSM1-transduced human islets confirmed endogenous INSM1 occupancy of the insulin promoter. Morpholino knockdown of INSM1 or cyclin D1 in fetal mouse pancreas enhances insulin promoter activity.","method":"Reporter gene assays with mutagenesis, ChIP, co-immunoprecipitation, morpholino knockdown","journal":"The Journal of endocrinology","confidence":"High","confidence_rationale":"Tier 1-2 / Strong — multiple orthogonal methods (ChIP, mutagenesis, morpholino KD, reporter assays) in multiple cell systems","pmids":["18417529"],"is_preprint":false},{"year":2008,"finding":"Insm1 is regulated downstream of Sonic Hedgehog signaling and is expressed in developing cerebellum granule cell progenitors; Insm1 and Nhlh1 are novel HH targets induced by Shh treatment in cultured cerebellar granule cell progenitors, and their expression is upregulated in HH-dependent medulloblastomas.","method":"Gene expression profiling, Shh treatment of cultured progenitors, Gli1 binding to Nhlh1 promoter","journal":"Neoplasia (New York, N.Y.)","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — direct Shh treatment experiment plus promoter binding, single lab","pmids":["18231642"],"is_preprint":false},{"year":2009,"finding":"INSM1 binds directly to cyclin D1 via the cyclin box domain; the proline-rich N-terminal region of INSM1 is required for this binding. INSM1 binding to cyclin D1 disrupts cyclin D1–CDK4 association, induces hypophosphorylation of pRb, and causes cell cycle arrest. Mutation of proline residues abolishes cyclin D1 binding and abrogates cell cycle arrest. INSM1 overexpression inhibits proliferation of Panc-1 cells in vitro and in nude mouse tumor models.","method":"Competitive pulldown, co-immunoprecipitation, Tet-on inducible expression system, cell cycle synchronization, serum starvation, MTT assay, soft agar colony formation, nude mouse xenograft, mutagenesis","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 1 / Strong — direct biochemical reconstitution of the INSM1–cyclin D1 interaction, mutagenesis, and multiple functional readouts including in vivo","pmids":["19124461"],"is_preprint":false},{"year":2009,"finding":"Insm1 is essential for the differentiation of serotonergic and noradrenergic neurons in the hindbrain. A conserved cis-regulatory sequence of Insm1 is directly bound and activated by Ascl1 in the ventral hindbrain. In Insm1-null mice, serotonergic fate determinants Pet1, Lmx1b, and Gata2 are markedly downregulated; Tph2 (tryptophan hydroxylase 2, key serotonin biosynthesis enzyme) fails to be activated. Both Insm1 and Ascl1 coordinately specify Tph2 expression. In brainstem noradrenergic centers, tyrosine hydroxylase expression is delayed/deficient in Insm1 mutants.","method":"Insm1-null mouse genetics, Ascl1 chromatin occupancy (ChIP at Insm1 regulatory element), epistatic analysis of downstream transcription factors","journal":"Development (Cambridge, England)","confidence":"High","confidence_rationale":"Tier 2 / Strong — genetic loss-of-function plus ChIP for Ascl1 at Insm1 locus, well-defined phenotypic readouts","pmids":["19542360"],"is_preprint":false},{"year":2011,"finding":"Insm1 promotes the transition of olfactory progenitors from apical/proliferative to basal/terminally-dividing and neuronogenic. Deletion of Insm1 in mice results in more apical progenitors expressing ASCL1, fewer basal/NEUROD1-expressing terminal progenitors, and fewer terminally dividing cells (confirmed by nucleoside analog pulse-chase). This role is partially conserved with the C. elegans ortholog egl-46.","method":"Insm1 knockout mouse, immunohistochemistry, nucleoside analog (BrdU/EdU) pulse-chase for cell division timing","journal":"Neural development","confidence":"High","confidence_rationale":"Tier 2 / Strong — genetic KO with defined progenitor pool quantification using orthogonal markers and pulse-chase","pmids":["21284846"],"is_preprint":false},{"year":2013,"finding":"Insm1 requires its N-terminal SNAG domain for function in vivo. The SNAG domain recruits histone-modifying factors including Kdm1a (LSD1), Hdac1/2, Rcor1-3, and other transcriptional regulators (Hmg20a/b, Gse1). Deletion of the SNAG domain in mice disrupted pituitary endocrine cell differentiation and caused upregulation of Notch pathway components and ectopic skeletal muscle gene expression, phenocopying full Insm1 deletion in the pituitary.","method":"SNAG domain deletion mouse model, mass spectrometry of Insm1 co-purifying proteins, co-immunoprecipitation, gene expression analysis","journal":"Development (Cambridge, England)","confidence":"High","confidence_rationale":"Tier 1-2 / Strong — domain deletion in vivo plus MS identification of co-purifying histone-modifying complexes","pmids":["24227653"],"is_preprint":false},{"year":2014,"finding":"INSM1 interacts with RACK1 through its proline-rich N-terminal region; this interaction disrupts RACK1–insulin receptor (InR) binding, enhancing InR-mediated signaling and increasing AKT phosphorylation. INSM1-enhanced AKT phosphorylation is blocked by the PI3K inhibitor LY294002. The INSM1/RACK1/InR pathway activates Nkx6.1 expression via increased acetyl-H4 modification of the Nkx6.1 promoter during AR42J cell trans-differentiation.","method":"Co-immunoprecipitation, competitive binding assay, phospho-AKT western blot, PI3K inhibitor treatment, ChIP for histone acetylation at Nkx6.1 promoter","journal":"Cellular signalling","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — Co-IP plus pharmacological inhibition plus ChIP, single lab","pmids":["24407176"],"is_preprint":false},{"year":2014,"finding":"Insm1 promotes the transition from ductal progenitor to committed endocrine cell in the pancreas by repressing a progenitor cell program and activating genes for RNA splicing, cell migration, cell proliferation, and hormone secretion. Insm1 positively regulates Neurog3 (reducing a non-coding Neurog3 mRNA splice variant in its absence), and regulates the proliferation inhibitor Ripply3.","method":"Insm1(GFPCre) reporter allele, flow-cytometry cell sorting, transcriptome analysis of Insm1-null populations, genetic analysis of Ripply3 function","journal":"Development (Cambridge, England)","confidence":"High","confidence_rationale":"Tier 2 / Strong — genetic reporter allele, FACS-sorted cell population transcriptomics, functional analysis of downstream target","pmids":["25053427"],"is_preprint":false},{"year":2015,"finding":"Insm1 directly interacts with Neurod1 and Foxa2, and this trimeric complex binds regulatory sequences in the genome of mature pancreatic beta cells. Ablation of Insm1 in mature beta cells causes deficits in insulin secretion; adult mutant beta cells resemble immature neonatal beta cells in gene expression. Combinatorial Insm1/Neurod1/Foxa2 binding—not Insm1 binding alone—explains the majority of gene expression changes.","method":"Conditional Insm1 ablation in adult beta cells, Co-immunoprecipitation, ChIP-seq for all three factors, gene expression analysis, functional insulin secretion assay","journal":"The EMBO journal","confidence":"High","confidence_rationale":"Tier 1-2 / Strong — ChIP-seq plus Co-IP plus conditional KO plus functional insulin secretion readout in a single study","pmids":["25828096"],"is_preprint":false},{"year":2015,"finding":"Insm1 is expressed downstream of Ascl1 in pulmonary neuroendocrine cells (Insm1 expression is absent in Ascl1-mutant lungs). Insm1 directly binds the Hes1 promoter and represses Hes1 expression; this Insm1-dependent Hes1 repression is required for neuroendocrine cell differentiation in the lung. Loss of Insm1 blocks terminal differentiation and upregulates Hes1 protein in neuroendocrine cells while interfering with Ascl1 maintenance.","method":"Ascl1 mutant mouse epistasis, Insm1 knockout mouse, ChIP for Insm1 on Hes1 promoter, immunohistochemistry, gene expression analysis","journal":"Developmental biology","confidence":"High","confidence_rationale":"Tier 1-2 / Strong — ChIP demonstrating direct Insm1 binding to Hes1 promoter, confirmed by genetic epistasis and KO phenotype","pmids":["26453796"],"is_preprint":false},{"year":2015,"finding":"INSM1 increases N-myc stability in neuroblastoma by activating the PI3K/AKT/GSK3β pathway, suppressing N-myc phosphorylation at Thr-58 and thereby inhibiting N-myc degradation. N-myc in turn binds the E2-box of the INSM1 promoter and activates INSM1 expression, forming a positive-feedback loop. The Sonic hedgehog pathway induces this loop.","method":"Overexpression and knockdown in neuroblastoma cells, PI3K/AKT pathway inhibition, phospho-N-myc western blot, ChIP for N-myc at INSM1 promoter, invasion assay, xenograft nude mouse model","journal":"Oncotarget","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — ChIP plus signaling pathway analysis plus in vivo xenograft, single lab","pmids":["26456864"],"is_preprint":false},{"year":2017,"finding":"INSM1 interacts with LSD1 (KDM1A) via its SNAG domain, and this interaction is required for neuroendocrine-associated gene expression and SCLC cell proliferation. The irreversible LSD1 inhibitor T-3775440 disrupts the LSD1–INSM1 interaction, inhibiting expression of neuroendocrine genes such as ASCL1 and reducing SCLC proliferation. INSM1 silencing phenocopies T-3775440 effects on gene expression and proliferation.","method":"Co-immunoprecipitation (LSD1–INSM1), LSD1 inhibitor treatment, INSM1 siRNA knockdown, gene expression analysis, in vitro and in vivo proliferation assays","journal":"Cancer research","confidence":"High","confidence_rationale":"Tier 2 / Strong — direct Co-IP demonstrating LSD1–INSM1 complex, pharmacological disruption, and genetic phenocopy by INSM1 silencing","pmids":["28667074"],"is_preprint":false},{"year":2017,"finding":"INSM1 forms complexes with REST corepressors RCOR1 and RCOR2 in embryonic mouse brain progenitors. The Insm1-/- mouse phenocopies predominant brain phenotypes of the Rcor1/2 double knockout, including abnormally high neural progenitor numbers, fewer differentiated neurons/OPC, and defective interganglionic sulcus closure. A large number of genes are concordantly misregulated in both knockouts, and REST transcripts are upregulated in both; reducing REST to control levels in the Rcor1/2 KO partially rescues the interganglionic sulcus defect.","method":"Co-immunoprecipitation (INSM1–RCOR1/2 in embryonic brain), double-knockout mouse genetics, transcriptome analysis, REST rescue experiment","journal":"Proceedings of the National Academy of Sciences of the United States of America","confidence":"High","confidence_rationale":"Tier 2 / Strong — Co-IP plus genetic epistasis (phenocopy and rescue) plus transcriptome comparison across two knockout genotypes","pmids":["28049845"],"is_preprint":false},{"year":2018,"finding":"Insm1 is transiently expressed in nascent outer hair cells (OHCs) but not inner hair cells (IHCs). In the absence of INSM1, many OHCs trans-differentiate into IHCs: INSM1 represses a core set of IHC-enriched genes in embryonic OHCs, rendering them unresponsive to an IHC-inducing gradient. Upregulation of IHC-enriched genes in INSM1-deficient OHCs identifies candidate genes for IHC-specific differentiation.","method":"Insm1 conditional knockout mouse, transcriptome comparison of immature IHCs vs OHCs with/without INSM1, immunohistochemistry, electrophysiology","journal":"Nature","confidence":"High","confidence_rationale":"Tier 2 / Strong — genetic KO with transcriptome analysis and functional cell-type transformation, published in Nature with multiple orthogonal methods","pmids":["30305733"],"is_preprint":false},{"year":2018,"finding":"Insm1 promotes delamination of neural progenitor cells (NPCs) from the ventricular surface during neocortex development by repressing Plekha7, an apical adherens junction belt-specific protein. Forced Insm1 expression converts apical to basal radial glia. CRISPR/Cas9 disruption of Plekha7 alone causes NPC delamination, and Plekha7 overexpression counteracts Insm1-induced delamination.","method":"In utero electroporation of Insm1, CRISPR/Cas9 knockout of Plekha7, Plekha7 overexpression rescue, live imaging, immunostaining","journal":"Neuron","confidence":"High","confidence_rationale":"Tier 1-2 / Strong — gain-of-function, CRISPR loss-of-function, and rescue experiments establishing the Insm1→Plekha7→delamination pathway","pmids":["29503187"],"is_preprint":false},{"year":2018,"finding":"The Sonic hedgehog signaling pathway activates INSM1 expression in SCLC through N-myc and Ascl1, both of which bind the E2-box in the INSM1 promoter. INSM1 in turn crosstalks with the Shh-PI3K/AKT-N-myc/Ascl1-MEK/ERK1/2 transcriptional network, enhancing N-myc stability. Knockdown of INSM1 or Shh inhibitors reduce NE lung cancer cell growth.","method":"Promoter reporter assays, ChIP for N-myc and Ascl1 at INSM1 E2-box, INSM1 knockdown, Shh inhibitor treatment, western blot for N-myc stability","journal":"Cellular signalling","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — ChIP plus reporter assays plus knockdown, single lab","pmids":["29501727"],"is_preprint":false},{"year":2019,"finding":"Insm1 expression determines the phenotype of pancreatic neuroendocrine tumors in the RIP1-Tag2 mouse model: high Insm1 expression correlates with insulinoma (localized, hormone-secreting), while loss of Insm1 correlates with nonfunctioning metastatic PanNETs. In human cell lines, Insm1-deficient cells express stem cell markers, are more invasive in vitro, and metastasize at higher rates in vivo. INSM1 promoter is hypermethylated in human nonfunctioning PanNETs.","method":"Mouse genetic crosses (RIP1-Tag2), Insm1 KO cell lines, in vitro invasion assay, in vivo metastasis assay, promoter methylation analysis","journal":"Oncogenesis","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — combined genetic mouse model and cell-line KO with in vivo metastasis readout, single lab","pmids":["30796198"],"is_preprint":false},{"year":2021,"finding":"Cross-talk among MEN1, p53, and Notch signaling regulates INSM1 expression and subcellular localization in pancreatic neuroendocrine tumor cells. Loss of MEN1 in a p53 wild-type background results in increased nuclear INSM1 expression and cell proliferation. Inhibition of Notch signaling in a p53 wild-type background reduces PanNET cell proliferation by repressing INSM1 transcription and nuclear localization.","method":"PanNET mouse model, human cell lines, human tissue analysis, INSM1 localization by immunostaining, Notch inhibitor treatment, MEN1/p53 genetic manipulation","journal":"Neoplasia (New York, N.Y.)","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — combination of mouse model, cell lines, and human tissue with functional inhibition experiments; single lab","pmids":["34352404"],"is_preprint":false},{"year":2023,"finding":"Epistasis analysis in cochlear hair cells reveals that Insm1 acts as a positive (but indirect) regulator of Ikzf2: Insm1 overexpression in IHCs leads to ectopic Ikzf2 expression; Ikzf2 expression is repressed in Insm1-deficient OHCs; forced Ikzf2 expression partially rescues OHC abnormalities in Insm1 mutants; and dual ablation of Insm1 and Ikzf2 produces the same OHC-to-IHC transdifferentiation phenotype as Insm1 ablation alone. This establishes a transcriptional cascade from Insm1 to Ikzf2 in OHC development.","method":"Insm1 overexpression in IHCs, Insm1 conditional KO, Ikzf2 conditional KO, Insm1/Ikzf2 double KO, Ikzf2 forced expression rescue, immunostaining","journal":"Cell reports","confidence":"High","confidence_rationale":"Tier 2 / Strong — genetic epistasis established by gain-of-function, loss-of-function, rescue, and double-KO experiments in the same tissue system","pmids":["37171961"],"is_preprint":false},{"year":2023,"finding":"Insm1 is broadly co-expressed with Aire in medullary thymic epithelial cells (mTECs). Insm1 mutation in mice downregulates Aire expression, dysregulates the mTEC gene expression program, alters mTEC subpopulations and tissue-restricted antigen expression, and causes autoimmune responses in peripheral tissues. Insm1 regulates gene expression in mTECs by direct chromatin binding; the majority of Insm1 binding sites are co-occupied by Aire and enriched in superenhancer regions.","method":"Insm1 mutant mouse, immunostaining, transcriptome analysis of mTECs, ChIP for Insm1 in mTECs, autoimmune phenotype assessment","journal":"Cellular & molecular immunology","confidence":"High","confidence_rationale":"Tier 2 / Strong — direct ChIP in mTECs plus genetic KO with autoimmune phenotype, co-occupancy with Aire at superenhancers","pmids":["37990032"],"is_preprint":false}],"current_model":"INSM1 is a nuclear zinc-finger transcriptional repressor (using a SNAG domain to recruit LSD1/HDAC/CoREST complexes and cyclin D1) that acts downstream of proneural factors (Ngn3, Ascl1) to drive terminal differentiation of neuroendocrine, neuronal, and sensory hair cell lineages by repressing progenitor/alternative-fate gene programs, inhibiting cell cycle progression through disruption of cyclin D1–CDK4 complexes, and participating in combinatorial transcription factor complexes (e.g., with Neurod1 and Foxa2) to maintain mature endocrine cell identity."},"narrative":{"mechanistic_narrative":"INSM1 is a nuclear C2H2 zinc-finger transcription factor that acts downstream of proneural factors (Ngn3, Ascl1/Mash1) to drive terminal differentiation of neuroendocrine, neuronal, and sensory lineages by repressing progenitor and alternative-fate gene programs [PMID:16951258, PMID:16511571, PMID:18094025, PMID:19542360, PMID:26453796]. Its architecture combines an N-terminal regulatory/SNAG region with five C-terminal zinc fingers that bind a defined consensus DNA element and confer transcriptional repression [PMID:1634555, PMID:11842116]. As a target of Ngn3/CBP and Ascl1, which bind and activate the INSM1 promoter/regulatory elements, INSM1 is induced at the progenitor-to-differentiated transition and can autoregulate its own promoter [PMID:11842116, PMID:16511571, PMID:17300785, PMID:19542360]. Repression is executed through its SNAG domain, which recruits histone-modifying complexes including LSD1 (KDM1A), HDAC1/2, and the REST corepressors RCOR1-3, and through recruitment of cyclin D1 and HDAC-3 to target promoters such as insulin and NeuroD/beta2 [PMID:16569215, PMID:18417529, PMID:24227653, PMID:28667074, PMID:28049845]. Beyond transcriptional repression, INSM1 binds cyclin D1 via its proline-rich N-terminus, disrupting cyclin D1–CDK4 association, causing pRb hypophosphorylation and cell-cycle arrest [PMID:19124461]. In mature endocrine cells INSM1 partners combinatorially with Neurod1 and Foxa2 to maintain differentiated identity and insulin secretion [PMID:25828096]. Loss of INSM1 produces failures or switches of cell fate across tissues—blocked endocrine, chromaffin, serotonergic/noradrenergic, and pulmonary neuroendocrine differentiation, transdifferentiation of outer to inner cochlear hair cells, retention of apical/proliferative progenitors, and autoimmune dysregulation in thymic epithelium [PMID:16951258, PMID:18094025, PMID:19542360, PMID:21284846, PMID:26453796, PMID:30305733, PMID:37990032]. INSM1 is also embedded in oncogenic neuroendocrine circuits, supporting SCLC and neuroblastoma proliferation and modulating pancreatic neuroendocrine tumor phenotype [PMID:26456864, PMID:28667074, PMID:30796198].","teleology":[{"year":1992,"claim":"Defining the protein's domain architecture established INSM1 as a candidate DNA-binding factor, framing all subsequent functional study.","evidence":"cDNA cloning and sequence/domain prediction identifying five C2H2 zinc fingers and an N-terminal putative prohormone region","pmids":["1634555"],"confidence":"High","gaps":["No DNA target or transcriptional activity demonstrated","Functional role of the N-terminal domain unresolved"]},{"year":1994,"claim":"Showing the gene is intronless and maps to chromosome 20p completed its basic structural characterization.","evidence":"Genomic cloning, in vitro translation, and in situ hybridization","pmids":["8188699"],"confidence":"High","gaps":["Does not address regulation or function","No cellular phenotype examined"]},{"year":2002,"claim":"Establishing INSM1 as a sequence-specific transcriptional repressor with a defined consensus site, autoregulation, and nuclear localization converted it from a sequence to a functional regulator and revealed an early interaction with CAP.","evidence":"GAL4 reporter and SELEX with GST-DBD, mutagenesis, plus yeast two-hybrid/Co-IP and GFP localization","pmids":["11842116","12079283"],"confidence":"High","gaps":["Mechanism of repression (corepressors) not yet identified","Functional significance of the CAP interaction unclear"]},{"year":2003,"claim":"Identifying the NeuroD1/E47-bound E-box in the INSM1 promoter placed INSM1 within an endocrine transcription factor hierarchy as a transcriptional target.","evidence":"Promoter deletion reporters, EMSA, and mutagenesis","pmids":["12890672"],"confidence":"High","gaps":["In vivo relevance of the E3 element not tested at this stage"]},{"year":2006,"claim":"Positioning INSM1 immediately downstream of Ngn3 and demonstrating it is essential for endocrine cell differentiation defined its core developmental role and its repressor mechanism via cyclin D1/HDAC recruitment.","evidence":"Ngn3-null epistasis and ChIP, Insm1 knockout mouse phenotyping, and ChIP/yeast two-hybrid/Co-IP for the cyclin D1–HDAC complex on NeuroD/beta2","pmids":["16511571","16951258","16569215"],"confidence":"High","gaps":["Genome-wide target repertoire not defined","Direct versus indirect target distinction limited to candidate promoters"]},{"year":2007,"claim":"Demonstrating Ngn3/CBP occupancy and histone hyperacetylation at the INSM1 promoter clarified how the upstream proneural factor activates INSM1 transcription.","evidence":"ChIP for Ngn3 and CBP, adenoviral overexpression, and histone acetylation assays","pmids":["17300785"],"confidence":"High","gaps":["Does not address downstream INSM1 targets"]},{"year":2007,"claim":"Extending INSM1 function to sympatho-adrenal differentiation placed it downstream of Mash1/Ascl1 and tied its loss to catecholamine-deficiency lethality.","evidence":"Insm1 knockout mouse with gene-expression and epistasis analysis","pmids":["18094025"],"confidence":"High","gaps":["Direct INSM1 target genes in this lineage not identified"]},{"year":2008,"claim":"Mapping INSM1 expression to late/basal neuronal progenitors and establishing direct repression of the insulin promoter via cyclin D1/HDAC-3 refined both where and how INSM1 acts.","evidence":"ISH/IHC localization across neurogenic zones; reporter mutagenesis, ChIP in multiple systems, and morpholino knockdown for insulin repression; plus Shh-induced expression in cerebellar progenitors","pmids":["18205207","18417529","18231642"],"confidence":"High","gaps":["Localization study single-lab and partly inferential","Shh-to-INSM1 link correlative for cerebellar progenitors"]},{"year":2009,"claim":"Biochemical reconstitution showed INSM1 binds cyclin D1 through its proline-rich N-terminus to disrupt cyclin D1–CDK4 and arrest the cell cycle, while genetics linked it to serotonergic/noradrenergic neuron differentiation downstream of Ascl1.","evidence":"Competitive pulldown, mutagenesis, Tet-on expression, xenografts; and Insm1-null mice with Ascl1 ChIP at the Insm1 regulatory element","pmids":["19124461","19542360"],"confidence":"High","gaps":["How cell-cycle and transcriptional-repressor functions are coordinated unresolved","Direct serotonergic target promoters not all defined"]},{"year":2011,"claim":"Showing INSM1 drives the apical-to-basal, proliferative-to-neuronogenic transition of olfactory progenitors connected its expression pattern to a concrete progenitor-transition function.","evidence":"Insm1 knockout mouse with marker analysis and nucleoside pulse-chase","pmids":["21284846"],"confidence":"High","gaps":["Molecular targets governing the transition not yet identified"]},{"year":2013,"claim":"Identifying the SNAG domain as the in vivo functional module that recruits LSD1/HDAC/CoREST machinery provided the mechanistic basis of INSM1-mediated repression.","evidence":"SNAG-deletion mouse, mass spectrometry of co-purifying proteins, and Co-IP","pmids":["24227653"],"confidence":"High","gaps":["Stoichiometry and locus-specific composition of the complex not resolved"]},{"year":2014,"claim":"Transcriptomics of sorted endocrine progenitors and a non-canonical RACK1/insulin-receptor signaling role broadened INSM1's mechanistic repertoire beyond classical repression.","evidence":"Insm1(GFPCre) reporter, FACS and transcriptome analysis of pancreatic populations; and Co-IP/competitive binding with RACK1/InR plus phospho-AKT and ChIP","pmids":["25053427","24407176"],"confidence":"High","gaps":["RACK1/InR signaling role is single-lab Medium-confidence","Cytoplasmic versus nuclear partition of these functions unclear"]},{"year":2015,"claim":"Defining a combinatorial Insm1/Neurod1/Foxa2 complex in mature beta cells and direct Hes1 repression in pulmonary neuroendocrine cells showed INSM1 maintains differentiated identity and antagonizes Notch effectors.","evidence":"Conditional beta-cell ablation with ChIP-seq/Co-IP and insulin-secretion assays; Ascl1-mutant epistasis with Insm1 ChIP at Hes1; plus N-myc positive-feedback work in neuroblastoma","pmids":["25828096","26453796","26456864"],"confidence":"High","gaps":["Genome-wide cooperativity rules between the three factors not fully defined","N-myc feedback loop Medium-confidence single-lab"]},{"year":2017,"claim":"Demonstrating direct SNAG-mediated LSD1 binding required for SCLC gene expression, and INSM1–RCOR1/2 complexes phenocopying Rcor1/2 knockouts in brain, solidified INSM1 as a recruiter of REST-corepressor/LSD1 machinery with therapeutic relevance.","evidence":"Co-IP, LSD1-inhibitor disruption and siRNA phenocopy in SCLC; Co-IP plus double-knockout genetics, transcriptomics, and REST rescue in embryonic brain","pmids":["28667074","28049845"],"confidence":"High","gaps":["Locus selectivity of LSD1/RCOR recruitment not resolved","How INSM1 represses REST itself unclear"]},{"year":2018,"claim":"Three studies showed INSM1 enforces cell-fate decisions: repressing IHC genes in outer hair cells, repressing Plekha7 to drive neural progenitor delamination, and feeding into the Shh/N-myc/Ascl1 circuit in SCLC.","evidence":"Cochlear conditional KO with transcriptomics/electrophysiology; in utero electroporation with Plekha7 CRISPR KO and rescue; promoter/ChIP and knockdown in SCLC","pmids":["30305733","29503187","29501727"],"confidence":"High","gaps":["Direct INSM1 binding at all relevant fate-gene loci not exhaustively mapped","SCLC Shh circuit Medium-confidence single-lab"]},{"year":2019,"claim":"Linking INSM1 level to pancreatic neuroendocrine tumor phenotype connected its differentiation function to tumor aggressiveness and metastasis.","evidence":"RIP1-Tag2 mouse crosses, Insm1-KO cell lines, invasion/metastasis assays, and promoter methylation analysis","pmids":["30796198"],"confidence":"Medium","gaps":["Single-lab; mechanism connecting INSM1 loss to stemness/invasion not defined","Causality of promoter hypermethylation not established"]},{"year":2021,"claim":"Showing MEN1/p53/Notch crosstalk controls INSM1 expression and nuclear localization extended understanding of how INSM1 is regulated in tumor contexts.","evidence":"PanNET mouse/cell/tissue models with Notch inhibition and MEN1/p53 manipulation, INSM1 immunostaining","pmids":["34352404"],"confidence":"Medium","gaps":["Single-lab correlative regulation","Direct molecular link from MEN1/p53/Notch to INSM1 promoter not defined"]},{"year":2023,"claim":"Defining the Insm1→Ikzf2 cascade in cochlear hair cells and INSM1/Aire co-occupancy at superenhancers in thymic epithelium revealed lineage-specific downstream targets and a new immunological role.","evidence":"Cochlear gain/loss/double-KO/rescue genetics; and Insm1-mutant mice with mTEC transcriptomics, Insm1 ChIP, and autoimmune phenotyping","pmids":["37171961","37990032"],"confidence":"High","gaps":["Whether Insm1 regulates Ikzf2 directly remains unresolved (indirect regulator)","Mechanism of INSM1–Aire co-regulation at superenhancers not detailed"]},{"year":null,"claim":"How INSM1 selects specific target loci across diverse lineages, and how its transcriptional-repressor and cyclin D1/cell-cycle functions are integrated, remains unresolved.","evidence":"No single study reconciles locus-selective corepressor recruitment with the cell-cycle-arrest mechanism across tissues","pmids":[],"confidence":"Low","gaps":["No unified model of context-specific target selection","Structural basis of zinc-finger DNA recognition in vivo not determined","Integration of nuclear repressor and cytoplasmic signaling roles unclear"]}],"mechanism_profile":{"molecular_activity":[{"term_id":"GO:0140110","term_label":"transcription regulator activity","supporting_discovery_ids":[2,5,11,19,20]},{"term_id":"GO:0003677","term_label":"DNA binding","supporting_discovery_ids":[2,20,30]},{"term_id":"GO:0098772","term_label":"molecular function regulator activity","supporting_discovery_ids":[13,16,22]},{"term_id":"GO:0060090","term_label":"molecular adaptor activity","supporting_discovery_ids":[16,19,23]}],"localization":[{"term_id":"GO:0005634","term_label":"nucleus","supporting_discovery_ids":[3,10,28]}],"pathway":[{"term_id":"R-HSA-1266738","term_label":"Developmental Biology","supporting_discovery_ids":[6,9,14,15,24,25]},{"term_id":"R-HSA-74160","term_label":"Gene expression (Transcription)","supporting_discovery_ids":[2,5,19,20]},{"term_id":"R-HSA-1640170","term_label":"Cell Cycle","supporting_discovery_ids":[13]}],"complexes":["LSD1/CoREST (KDM1A-RCOR-HDAC) complex","INSM1-Neurod1-Foxa2 complex","INSM1-cyclin D1-HDAC repressor complex"],"partners":["CCND1","KDM1A","HDAC1","RCOR1","NEUROD1","FOXA2","RACK1","HDAC3"],"other_free_text":[]}},"prefetch_data":{"uniprot":{"accession":"Q01101","full_name":"Insulinoma-associated protein 1","aliases":["Zinc finger protein IA-1"],"length_aa":510,"mass_kda":52.9,"function":"Sequence-specific DNA-binding transcriptional regulator that plays a key role in neurogenesis and neuroendocrine cell differentiation during embryonic and/or fetal development. Binds to the consensus sequence 5'-[TG][TC][TC][TT][GA]GGG[CG]A-3' in target promoters. Acts as a transcriptional repressor of NEUROD1 and INS expression via its interaction with cyclin CCND1 in a cell cycle-independent manner. Negatively regulates skeletal muscle-specific gene expression in endocrine cells of the pituitary by inhibiting the Notch signaling pathway. Represses target gene transcription by recruiting chromatin-modifying factors, such as HDAC1, HDAC2, HDAC3, KDM1A and RCOR1 histone deacetylases. Binds to its own promoter, suggesting autoregulation as a self-control feedback mechanism. Competes with histone H3 for the same binding site on the histone demethylase complex formed by KDM1A and RCOR1, and thereby inhibits demethylation of histone H3 at 'Lys-4' (PubMed:23721412). Promotes the generation and expansion of neuronal basal progenitor cells in the developing neocortex. Involved in the differentiation of endocrine cells of the developing anterior pituitary gland, of the pancreas and intestine, and of sympatho-adrenal cells in the peripheral nervous system. Promotes cell cycle signaling arrest and inhibition of cellular proliferation","subcellular_location":"Nucleus","url":"https://www.uniprot.org/uniprotkb/Q01101/entry"},"depmap":{"release":"DepMap","has_data":true,"is_common_essential":false,"resolved_as":"","url":"https://depmap.org/portal/gene/INSM1","classification":"Not Classified","n_dependent_lines":9,"n_total_lines":1208,"dependency_fraction":0.0074503311258278145},"opencell":{"profiled":false,"resolved_as":"","ensg_id":"","cell_line_id":"","localizations":[],"interactors":[],"url":"https://opencell.sf.czbiohub.org/search/INSM1","total_profiled":1310},"omim":[{"mim_id":"614027","title":"INSULINOMA-ASSOCIATED 2; INSM2","url":"https://www.omim.org/entry/614027"},{"mim_id":"600010","title":"INSULINOMA-ASSOCIATED 1; INSM1","url":"https://www.omim.org/entry/600010"}],"hpa":{"profiled":true,"resolved_as":"","reliability":"","locations":[],"tissue_specificity":"Tissue enhanced","tissue_distribution":"Detected in some","driving_tissues":[{"tissue":"brain","ntpm":14.9},{"tissue":"pituitary gland","ntpm":27.3}],"url":"https://www.proteinatlas.org/search/INSM1"},"hgnc":{"alias_symbol":["IA-1","IA1"],"prev_symbol":[]},"alphafold":{"accession":"Q01101","domains":[{"cath_id":"-","chopping":"268-318","consensus_level":"high","plddt":81.8535,"start":268,"end":318},{"cath_id":"3.30.160","chopping":"367-396","consensus_level":"medium","plddt":81.575,"start":367,"end":396}],"viewer_url":"https://alphafold.ebi.ac.uk/entry/Q01101","model_url":"https://alphafold.ebi.ac.uk/files/AF-Q01101-F1-model_v6.cif","pae_url":"https://alphafold.ebi.ac.uk/files/AF-Q01101-F1-predicted_aligned_error_v6.png","plddt_mean":58.38},"mouse_models":{"mgi_url":"https://www.informatics.jax.org/marker/summary?nomen=INSM1","jax_strain_url":"https://www.jax.org/strain/search?query=INSM1"},"sequence":{"accession":"Q01101","fasta_url":"https://rest.uniprot.org/uniprotkb/Q01101.fasta","uniprot_url":"https://www.uniprot.org/uniprotkb/Q01101/entry","alphafold_viewer_url":"https://alphafold.ebi.ac.uk/entry/Q01101"}},"corpus_meta":[{"pmid":"16951258","id":"PMC_16951258","title":"The zinc-finger factor Insm1 (IA-1) is essential for the development of pancreatic beta cells and intestinal endocrine cells.","date":"2006","source":"Genes & development","url":"https://pubmed.ncbi.nlm.nih.gov/16951258","citation_count":179,"is_preprint":false},{"pmid":"26386079","id":"PMC_26386079","title":"INSM1: A Novel Immunohistochemical and Molecular Marker for Neuroendocrine and Neuroepithelial Neoplasms.","date":"2015","source":"American journal of clinical pathology","url":"https://pubmed.ncbi.nlm.nih.gov/26386079","citation_count":153,"is_preprint":false},{"pmid":"16511571","id":"PMC_16511571","title":"IA1 is NGN3-dependent and essential for differentiation of the endocrine pancreas.","date":"2006","source":"The EMBO journal","url":"https://pubmed.ncbi.nlm.nih.gov/16511571","citation_count":149,"is_preprint":false},{"pmid":"28719469","id":"PMC_28719469","title":"INSM1 Demonstrates Superior Performance to the Individual and Combined Use of Synaptophysin, Chromogranin and CD56 for Diagnosing Neuroendocrine Tumors of the Thoracic Cavity.","date":"2017","source":"The American journal of surgical pathology","url":"https://pubmed.ncbi.nlm.nih.gov/28719469","citation_count":143,"is_preprint":false},{"pmid":"1634555","id":"PMC_1634555","title":"A novel human insulinoma-associated cDNA, IA-1, encodes a protein with \"zinc-finger\" DNA-binding motifs.","date":"1992","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/1634555","citation_count":141,"is_preprint":false},{"pmid":"29088741","id":"PMC_29088741","title":"Reciprocal expression of INSM1 and YAP1 defines subgroups in small cell lung cancer.","date":"2017","source":"Oncotarget","url":"https://pubmed.ncbi.nlm.nih.gov/29088741","citation_count":135,"is_preprint":false},{"pmid":"29438167","id":"PMC_29438167","title":"INSM1 is a Sensitive and Specific Marker of Neuroendocrine Differentiation in Head and Neck Tumors.","date":"2018","source":"The American journal of surgical pathology","url":"https://pubmed.ncbi.nlm.nih.gov/29438167","citation_count":126,"is_preprint":false},{"pmid":"19246490","id":"PMC_19246490","title":"Structure, expression, and biological function of INSM1 transcription factor in neuroendocrine differentiation.","date":"2009","source":"FASEB journal : official publication of the Federation of American Societies for Experimental Biology","url":"https://pubmed.ncbi.nlm.nih.gov/19246490","citation_count":118,"is_preprint":false},{"pmid":"30154579","id":"PMC_30154579","title":"Insulinoma-associated protein 1 (INSM1) is a sensitive and highly specific marker of neuroendocrine differentiation in primary lung neoplasms: an immunohistochemical study of 345 cases, including 292 whole-tissue sections.","date":"2018","source":"Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc","url":"https://pubmed.ncbi.nlm.nih.gov/30154579","citation_count":108,"is_preprint":false},{"pmid":"1374245","id":"PMC_1374245","title":"Interleukin-6 down regulates the expression of transcripts encoding cytochrome P450 IA1, IA2 and IIIA3 in human hepatoma cells.","date":"1992","source":"Biochemical and biophysical research communications","url":"https://pubmed.ncbi.nlm.nih.gov/1374245","citation_count":101,"is_preprint":false},{"pmid":"18094025","id":"PMC_18094025","title":"Insm1 (IA-1) is a crucial component of the transcriptional network that controls differentiation of the sympatho-adrenal lineage.","date":"2007","source":"Development (Cambridge, England)","url":"https://pubmed.ncbi.nlm.nih.gov/18094025","citation_count":98,"is_preprint":false},{"pmid":"30305733","id":"PMC_30305733","title":"Trans-differentiation of outer hair cells into inner hair cells in the absence of INSM1.","date":"2018","source":"Nature","url":"https://pubmed.ncbi.nlm.nih.gov/30305733","citation_count":85,"is_preprint":false},{"pmid":"28849340","id":"PMC_28849340","title":"Insulinoma-associated protein 1 (INSM1) is a useful marker for pancreatic neuroendocrine tumor.","date":"2017","source":"Medical molecular morphology","url":"https://pubmed.ncbi.nlm.nih.gov/28849340","citation_count":82,"is_preprint":false},{"pmid":"25828096","id":"PMC_25828096","title":"Insm1 cooperates with Neurod1 and Foxa2 to maintain mature pancreatic β-cell function.","date":"2015","source":"The EMBO journal","url":"https://pubmed.ncbi.nlm.nih.gov/25828096","citation_count":79,"is_preprint":false},{"pmid":"28667074","id":"PMC_28667074","title":"LSD1 Inhibitor T-3775440 Inhibits SCLC Cell Proliferation by Disrupting LSD1 Interactions with SNAG Domain Proteins INSM1 and GFI1B.","date":"2017","source":"Cancer research","url":"https://pubmed.ncbi.nlm.nih.gov/28667074","citation_count":78,"is_preprint":false},{"pmid":"12890672","id":"PMC_12890672","title":"NeuroD1/E47 regulates the E-box element of a novel zinc finger transcription factor, IA-1, in developing nervous system.","date":"2003","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/12890672","citation_count":78,"is_preprint":false},{"pmid":"11842116","id":"PMC_11842116","title":"Neuroendocrine differentiation factor, IA-1, is a transcriptional repressor and contains a specific DNA-binding domain: identification of consensus IA-1 binding sequence.","date":"2002","source":"Nucleic acids research","url":"https://pubmed.ncbi.nlm.nih.gov/11842116","citation_count":77,"is_preprint":false},{"pmid":"27908529","id":"PMC_27908529","title":"A new marker, insulinoma-associated protein 1 (INSM1), for high-grade neuroendocrine carcinoma of the uterine cervix: Analysis of 37 cases.","date":"2016","source":"Gynecologic oncology","url":"https://pubmed.ncbi.nlm.nih.gov/27908529","citation_count":73,"is_preprint":false},{"pmid":"30080705","id":"PMC_30080705","title":"INSM1 Is More Sensitive and Interpretable than Conventional Immunohistochemical Stains Used to Diagnose Merkel Cell Carcinoma.","date":"2018","source":"The American journal of surgical pathology","url":"https://pubmed.ncbi.nlm.nih.gov/30080705","citation_count":71,"is_preprint":false},{"pmid":"29503187","id":"PMC_29503187","title":"Insm1 Induces Neural Progenitor Delamination in Developing Neocortex via Downregulation of the Adherens Junction Belt-Specific Protein Plekha7.","date":"2018","source":"Neuron","url":"https://pubmed.ncbi.nlm.nih.gov/29503187","citation_count":66,"is_preprint":false},{"pmid":"8364910","id":"PMC_8364910","title":"IA-1, a new marker for neuroendocrine differentiation in human lung cancer cell lines.","date":"1993","source":"Cancer research","url":"https://pubmed.ncbi.nlm.nih.gov/8364910","citation_count":64,"is_preprint":false},{"pmid":"29327709","id":"PMC_29327709","title":"INSM1 expression and its diagnostic significance in extraskeletal myxoid chondrosarcoma.","date":"2018","source":"Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc","url":"https://pubmed.ncbi.nlm.nih.gov/29327709","citation_count":63,"is_preprint":false},{"pmid":"28049845","id":"PMC_28049845","title":"REST corepressors RCOR1 and RCOR2 and the repressor INSM1 regulate the proliferation-differentiation balance in the developing brain.","date":"2017","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/28049845","citation_count":63,"is_preprint":false},{"pmid":"18205207","id":"PMC_18205207","title":"Transient expression of the conserved zinc finger gene INSM1 in progenitors and nascent neurons throughout embryonic and adult neurogenesis.","date":"2008","source":"The Journal of comparative neurology","url":"https://pubmed.ncbi.nlm.nih.gov/18205207","citation_count":60,"is_preprint":false},{"pmid":"25053427","id":"PMC_25053427","title":"Insm1 promotes endocrine cell differentiation by modulating the expression of a network of genes that includes Neurog3 and Ripply3.","date":"2014","source":"Development (Cambridge, England)","url":"https://pubmed.ncbi.nlm.nih.gov/25053427","citation_count":58,"is_preprint":false},{"pmid":"32128564","id":"PMC_32128564","title":"INSM1 Is a Highly Specific Marker of Neuroendocrine Differentiation in Primary Neoplasms of the Gastrointestinal Tract, Appendix, and Pancreas.","date":"2020","source":"American journal of clinical pathology","url":"https://pubmed.ncbi.nlm.nih.gov/32128564","citation_count":53,"is_preprint":false},{"pmid":"1918043","id":"PMC_1918043","title":"The active sites of cytochromes P450 IA1, IIB1, IIB2, and IIE1. Topological analysis by in situ rearrangement of phenyl-iron complexes.","date":"1991","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/1918043","citation_count":52,"is_preprint":false},{"pmid":"16569215","id":"PMC_16569215","title":"INSM1 functions as a transcriptional repressor of the neuroD/beta2 gene through the recruitment of cyclin D1 and histone deacetylases.","date":"2006","source":"The Biochemical journal","url":"https://pubmed.ncbi.nlm.nih.gov/16569215","citation_count":51,"is_preprint":false},{"pmid":"31913660","id":"PMC_31913660","title":"Diagnostic Value of Insulinoma-Associated Protein 1 (INSM1) and Comparison With Established Neuroendocrine Markers in Pulmonary Cancers.","date":"2020","source":"Archives of pathology & laboratory medicine","url":"https://pubmed.ncbi.nlm.nih.gov/31913660","citation_count":50,"is_preprint":false},{"pmid":"20177290","id":"PMC_20177290","title":"Fertility-conserving surgery for young women with stage IA1 cervical cancer: safety and access.","date":"2010","source":"Obstetrics and gynecology","url":"https://pubmed.ncbi.nlm.nih.gov/20177290","citation_count":48,"is_preprint":false},{"pmid":"19124461","id":"PMC_19124461","title":"Zinc finger transcription factor INSM1 interrupts cyclin D1 and CDK4 binding and induces cell cycle arrest.","date":"2009","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/19124461","citation_count":47,"is_preprint":false},{"pmid":"12079283","id":"PMC_12079283","title":"The zinc-finger transcription factor INSM1 is expressed during embryo development and interacts with the Cbl-associated protein.","date":"2002","source":"Genomics","url":"https://pubmed.ncbi.nlm.nih.gov/12079283","citation_count":47,"is_preprint":false},{"pmid":"19542360","id":"PMC_19542360","title":"Insm1 (IA-1) is an essential component of the regulatory network that specifies monoaminergic neuronal phenotypes in the vertebrate hindbrain.","date":"2009","source":"Development (Cambridge, England)","url":"https://pubmed.ncbi.nlm.nih.gov/19542360","citation_count":46,"is_preprint":false},{"pmid":"32813226","id":"PMC_32813226","title":"Clinical Routine Application of the Second-generation Neuroendocrine Markers ISL1, INSM1, and Secretagogin in Neuroendocrine Neoplasia: Staining Outcomes and Potential Clues for Determining Tumor Origin.","date":"2020","source":"Endocrine pathology","url":"https://pubmed.ncbi.nlm.nih.gov/32813226","citation_count":46,"is_preprint":false},{"pmid":"9932559","id":"PMC_9932559","title":"Stage IA1 cervical adenocarcinoma: definition and treatment.","date":"1999","source":"Obstetrics and gynecology","url":"https://pubmed.ncbi.nlm.nih.gov/9932559","citation_count":46,"is_preprint":false},{"pmid":"26453796","id":"PMC_26453796","title":"Insm1 controls the differentiation of pulmonary neuroendocrine cells by repressing Hes1.","date":"2015","source":"Developmental biology","url":"https://pubmed.ncbi.nlm.nih.gov/26453796","citation_count":45,"is_preprint":false},{"pmid":"24227653","id":"PMC_24227653","title":"Insm1 controls development of pituitary endocrine cells and requires a SNAG domain for function and for recruitment of histone-modifying factors.","date":"2013","source":"Development (Cambridge, England)","url":"https://pubmed.ncbi.nlm.nih.gov/24227653","citation_count":45,"is_preprint":false},{"pmid":"14658592","id":"PMC_14658592","title":"The clinical outcome of patients with stage Ia1 and Ia2 squamous cell carcinoma of the uterine cervix: a Cooperation Task Force (CTF) study.","date":"2003","source":"European journal of gynaecological oncology","url":"https://pubmed.ncbi.nlm.nih.gov/14658592","citation_count":44,"is_preprint":false},{"pmid":"18231642","id":"PMC_18231642","title":"An integrated approach identifies Nhlh1 and Insm1 as Sonic Hedgehog-regulated genes in developing cerebellum and medulloblastoma.","date":"2008","source":"Neoplasia (New York, N.Y.)","url":"https://pubmed.ncbi.nlm.nih.gov/18231642","citation_count":43,"is_preprint":false},{"pmid":"21284846","id":"PMC_21284846","title":"Insm1 promotes the transition of olfactory progenitors from apical and proliferative to basal, terminally dividing and neuronogenic.","date":"2011","source":"Neural development","url":"https://pubmed.ncbi.nlm.nih.gov/21284846","citation_count":43,"is_preprint":false},{"pmid":"31487963","id":"PMC_31487963","title":"Function and Transcriptional Regulation of Bovine TORC2 Gene in Adipocytes: Roles of C/EBP, XBP1, INSM1 and ZNF263.","date":"2019","source":"International journal of molecular sciences","url":"https://pubmed.ncbi.nlm.nih.gov/31487963","citation_count":42,"is_preprint":false},{"pmid":"1788977","id":"PMC_1788977","title":"Xenobiotic induction of P-450 PB-4 (IIB1) and P-450c (IA1) and associated monooxygenase activities in primary cultures of adult rat hepatocytes.","date":"1991","source":"Xenobiotica; the fate of foreign compounds in biological systems","url":"https://pubmed.ncbi.nlm.nih.gov/1788977","citation_count":42,"is_preprint":false},{"pmid":"26545349","id":"PMC_26545349","title":"Insm1 promotes neurogenic proliferation in delaminated otic progenitors.","date":"2015","source":"Mechanisms of development","url":"https://pubmed.ncbi.nlm.nih.gov/26545349","citation_count":41,"is_preprint":false},{"pmid":"30358615","id":"PMC_30358615","title":"Insulinoma-associated Protein 1 (INSM1) in Thoracic Tumors is Less Sensitive but More Specific Compared With Synaptophysin, Chromogranin A, and CD56.","date":"2020","source":"Applied immunohistochemistry & molecular morphology : AIMM","url":"https://pubmed.ncbi.nlm.nih.gov/30358615","citation_count":41,"is_preprint":false},{"pmid":"1889414","id":"PMC_1889414","title":"Induction, regulation and messenger half-life of cytochromes P450 IA1, IA2 and IIIA6 in primary cultures of rabbit hepatocytes. CYP 1A1, 1A2 and 3A6 chromosome location in the rabbit and evidence that post-transcriptional control of gene IA2 does not involve mRNA stabilization.","date":"1991","source":"European journal of biochemistry","url":"https://pubmed.ncbi.nlm.nih.gov/1889414","citation_count":39,"is_preprint":false},{"pmid":"32203089","id":"PMC_32203089","title":"INSM1 expression in a subset of thoracic malignancies and small round cell tumors: rare potential pitfalls for small cell carcinoma.","date":"2020","source":"Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc","url":"https://pubmed.ncbi.nlm.nih.gov/32203089","citation_count":38,"is_preprint":false},{"pmid":"10926806","id":"PMC_10926806","title":"Prospective management of stage IA(1) cervical adenocarcinoma by conization alone to preserve fertility: a preliminary report.","date":"2000","source":"Gynecologic oncology","url":"https://pubmed.ncbi.nlm.nih.gov/10926806","citation_count":38,"is_preprint":false},{"pmid":"34943408","id":"PMC_34943408","title":"INSM1, a Novel Biomarker for Detection of Neuroendocrine Neoplasms: Cytopathologists' View.","date":"2021","source":"Diagnostics (Basel, Switzerland)","url":"https://pubmed.ncbi.nlm.nih.gov/34943408","citation_count":36,"is_preprint":false},{"pmid":"11854618","id":"PMC_11854618","title":"Expression of a novel zinc-finger cDNA, IA-1, is associated with rat AR42J cells differentiation into insulin-positive cells.","date":"2002","source":"Pancreas","url":"https://pubmed.ncbi.nlm.nih.gov/11854618","citation_count":31,"is_preprint":false},{"pmid":"34431104","id":"PMC_34431104","title":"Reciprocal YAP1 loss and INSM1 expression in neuroendocrine prostate cancer.","date":"2021","source":"The Journal of pathology","url":"https://pubmed.ncbi.nlm.nih.gov/34431104","citation_count":30,"is_preprint":false},{"pmid":"12476009","id":"PMC_12476009","title":"Comparison of activities dependent on glutathione S-transferase and cytochrome P-450 IA1 in cultured keratinocytes and reconstructed epidermal models.","date":"2002","source":"Skin pharmacology and applied skin physiology","url":"https://pubmed.ncbi.nlm.nih.gov/12476009","citation_count":30,"is_preprint":false},{"pmid":"29501727","id":"PMC_29501727","title":"Sonic hedgehog signaling pathway promotes INSM1 transcription factor in neuroendocrine lung cancer.","date":"2018","source":"Cellular signalling","url":"https://pubmed.ncbi.nlm.nih.gov/29501727","citation_count":29,"is_preprint":false},{"pmid":"32219703","id":"PMC_32219703","title":"Insulinoma-associated protein 1 (INSM1): a potential biomarker and therapeutic target for neuroendocrine tumors.","date":"2020","source":"Cellular oncology (Dordrecht, Netherlands)","url":"https://pubmed.ncbi.nlm.nih.gov/32219703","citation_count":28,"is_preprint":false},{"pmid":"30796198","id":"PMC_30796198","title":"Alleles of Insm1 determine whether RIP1-Tag2 mice produce insulinomas or nonfunctioning pancreatic neuroendocrine tumors.","date":"2019","source":"Oncogenesis","url":"https://pubmed.ncbi.nlm.nih.gov/30796198","citation_count":28,"is_preprint":false},{"pmid":"8339279","id":"PMC_8339279","title":"Hepatic cellular distribution of cytochrome P-450 IA1 in rainbow trout (Oncorhynchus mykiss): an immunohisto- and cytochemical study.","date":"1993","source":"Cancer research","url":"https://pubmed.ncbi.nlm.nih.gov/8339279","citation_count":28,"is_preprint":false},{"pmid":"30523500","id":"PMC_30523500","title":"Expression of Insulinoma-Associated Protein 1 (INSM1) and Orthopedia Homeobox (OTP) in Tumors with Neuroendocrine Differentiation at Rare Sites.","date":"2019","source":"Endocrine pathology","url":"https://pubmed.ncbi.nlm.nih.gov/30523500","citation_count":27,"is_preprint":false},{"pmid":"32381384","id":"PMC_32381384","title":"Expression of novel neuroendocrine marker insulinoma-associated protein 1 (INSM1) in genitourinary high-grade neuroendocrine carcinomas: An immunohistochemical study with specificity analysis and comparison to chromogranin, synaptophysin, and CD56.","date":"2020","source":"Pathology, research and practice","url":"https://pubmed.ncbi.nlm.nih.gov/32381384","citation_count":27,"is_preprint":false},{"pmid":"8188699","id":"PMC_8188699","title":"Genomic organization, 5'-upstream sequence, and chromosomal localization of an insulinoma-associated intronless gene, IA-1.","date":"1994","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/8188699","citation_count":27,"is_preprint":false},{"pmid":"33264139","id":"PMC_33264139","title":"INSM1 Is Less Sensitive But More Specific Than Synaptophysin in Gynecologic High-grade Neuroendocrine Carcinomas: An Immunohistochemical Study of 75 Cases With Specificity Test and Literature Review.","date":"2021","source":"The American journal of surgical pathology","url":"https://pubmed.ncbi.nlm.nih.gov/33264139","citation_count":26,"is_preprint":false},{"pmid":"19407568","id":"PMC_19407568","title":"Conization using electrosurgical conization and cold coagulation for international federation of gynecology and obstetrics stage IA1 squamous cell carcinomas of the uterine cervix.","date":"2009","source":"International journal of gynecological cancer : official journal of the International Gynecological Cancer Society","url":"https://pubmed.ncbi.nlm.nih.gov/19407568","citation_count":26,"is_preprint":false},{"pmid":"31031215","id":"PMC_31031215","title":"A new immunohistochemical marker, insulinoma-associated protein 1 (INSM1), for Merkel cell carcinoma: Evaluation of 24 cases.","date":"2019","source":"Annals of diagnostic pathology","url":"https://pubmed.ncbi.nlm.nih.gov/31031215","citation_count":25,"is_preprint":false},{"pmid":"31977134","id":"PMC_31977134","title":"Insulinoma-associated protein 1 (INSM1) is a robust marker for identifying and grading pancreatic neuroendocrine tumors.","date":"2020","source":"Cancer cytopathology","url":"https://pubmed.ncbi.nlm.nih.gov/31977134","citation_count":22,"is_preprint":false},{"pmid":"12893205","id":"PMC_12893205","title":"Stage Ia1 cervical squamous cell carcinoma: conservative management after laser conization with positive margins.","date":"2003","source":"Gynecologic oncology","url":"https://pubmed.ncbi.nlm.nih.gov/12893205","citation_count":22,"is_preprint":false},{"pmid":"18417529","id":"PMC_18417529","title":"Identification of an INSM1-binding site in the insulin promoter: negative regulation of the insulin gene transcription.","date":"2008","source":"The Journal of endocrinology","url":"https://pubmed.ncbi.nlm.nih.gov/18417529","citation_count":22,"is_preprint":false},{"pmid":"21830214","id":"PMC_21830214","title":"Functional role of an islet transcription factor, INSM1/IA-1, on pancreatic acinar cell trans-differentiation.","date":"2012","source":"Journal of cellular physiology","url":"https://pubmed.ncbi.nlm.nih.gov/21830214","citation_count":21,"is_preprint":false},{"pmid":"17300785","id":"PMC_17300785","title":"Neurogenin 3 recruits CBP co-activator to facilitate histone H3/H4 acetylation in the target gene INSM1.","date":"2007","source":"FEBS letters","url":"https://pubmed.ncbi.nlm.nih.gov/17300785","citation_count":21,"is_preprint":false},{"pmid":"32670859","id":"PMC_32670859","title":"Silencing SCAMP1-TV2 Inhibited the Malignant Biological Behaviors of Breast Cancer Cells by Interaction With PUM2 to Facilitate INSM1 mRNA Degradation.","date":"2020","source":"Frontiers in oncology","url":"https://pubmed.ncbi.nlm.nih.gov/32670859","citation_count":21,"is_preprint":false},{"pmid":"34008122","id":"PMC_34008122","title":"INSM1 Expression in Breast Neoplasms with Neuroedocrine Features.","date":"2021","source":"Endocrine pathology","url":"https://pubmed.ncbi.nlm.nih.gov/34008122","citation_count":20,"is_preprint":false},{"pmid":"29938548","id":"PMC_29938548","title":"CD10, TDAG51, CK20, AR, INSM1, and Nestin Expression in the Differential Diagnosis of Trichoblastoma and Basal Cell Carcinoma.","date":"2018","source":"International journal of surgical pathology","url":"https://pubmed.ncbi.nlm.nih.gov/29938548","citation_count":20,"is_preprint":false},{"pmid":"30385371","id":"PMC_30385371","title":"Triple marker composed of p16, CD56, and TTF1 shows higher sensitivity than INSM1 for diagnosis of pulmonary small cell carcinoma: proposal for a rational immunohistochemical algorithm for diagnosis of small cell carcinoma in small biopsy and cytology specimens.","date":"2018","source":"Human pathology","url":"https://pubmed.ncbi.nlm.nih.gov/30385371","citation_count":20,"is_preprint":false},{"pmid":"1677846","id":"PMC_1677846","title":"Application of a cytochrome P-450 IA1-ELISA in environmental monitoring and toxicological testing of fish.","date":"1991","source":"Comparative biochemistry and physiology. C, Comparative pharmacology and toxicology","url":"https://pubmed.ncbi.nlm.nih.gov/1677846","citation_count":20,"is_preprint":false},{"pmid":"16487754","id":"PMC_16487754","title":"Expression of two insm1-like genes in the developing zebrafish nervous system.","date":"2006","source":"Gene expression patterns : GEP","url":"https://pubmed.ncbi.nlm.nih.gov/16487754","citation_count":19,"is_preprint":false},{"pmid":"29490065","id":"PMC_29490065","title":"INSM1 Expression Is Frequent in Primary Central Nervous System Neoplasms but Not in the Adult Brain Parenchyma.","date":"2018","source":"Journal of neuropathology and experimental neurology","url":"https://pubmed.ncbi.nlm.nih.gov/29490065","citation_count":19,"is_preprint":false},{"pmid":"26456864","id":"PMC_26456864","title":"INSM1 increases N-myc stability and oncogenesis via a positive-feedback loop in neuroblastoma.","date":"2015","source":"Oncotarget","url":"https://pubmed.ncbi.nlm.nih.gov/26456864","citation_count":18,"is_preprint":false},{"pmid":"24407176","id":"PMC_24407176","title":"Extra-nuclear activity of INSM1 transcription factor enhances insulin receptor signaling pathway and Nkx6.1 expression through RACK1 interaction.","date":"2014","source":"Cellular signalling","url":"https://pubmed.ncbi.nlm.nih.gov/24407176","citation_count":18,"is_preprint":false},{"pmid":"35442742","id":"PMC_35442742","title":"Insm1-expressing neurons and secretory cells develop from a common pool of progenitors in the sea anemone Nematostella vectensis.","date":"2022","source":"Science advances","url":"https://pubmed.ncbi.nlm.nih.gov/35442742","citation_count":18,"is_preprint":false},{"pmid":"37171961","id":"PMC_37171961","title":"Epistatic genetic interactions between Insm1 and Ikzf2 during cochlear outer hair cell development.","date":"2023","source":"Cell reports","url":"https://pubmed.ncbi.nlm.nih.gov/37171961","citation_count":17,"is_preprint":false},{"pmid":"39113601","id":"PMC_39113601","title":"Pro-inflammatory activity of Cutibacterium acnes phylotype IA1 and extracellular vesicles: An in vitro study.","date":"2024","source":"Experimental dermatology","url":"https://pubmed.ncbi.nlm.nih.gov/39113601","citation_count":17,"is_preprint":false},{"pmid":"32197966","id":"PMC_32197966","title":"Insulinoma-associated protein 1 (INSM-1) expression in medullary thyroid carcinoma FNA: a multi-institutional study.","date":"2020","source":"Journal of the American Society of Cytopathology","url":"https://pubmed.ncbi.nlm.nih.gov/32197966","citation_count":16,"is_preprint":false},{"pmid":"34352404","id":"PMC_34352404","title":"Cross-talk among MEN1, p53 and Notch regulates the proliferation of pancreatic neuroendocrine tumor cells by modulating INSM1 expression and subcellular localization.","date":"2021","source":"Neoplasia (New York, N.Y.)","url":"https://pubmed.ncbi.nlm.nih.gov/34352404","citation_count":16,"is_preprint":false},{"pmid":"32724402","id":"PMC_32724402","title":"Conditional survival rate estimates of lobectomy, segmentectomy and wedge resection for stage IA1 non-small cell lung cancer: A population-based study.","date":"2020","source":"Oncology letters","url":"https://pubmed.ncbi.nlm.nih.gov/32724402","citation_count":16,"is_preprint":false},{"pmid":"14506618","id":"PMC_14506618","title":"Genetic effects of estrogen receptor alpha and collagen IA1 genes on the relationships of parathyroid hormone and 25 hydroxyvitamin D with bone mineral density in Caucasian women.","date":"2003","source":"Metabolism: clinical and experimental","url":"https://pubmed.ncbi.nlm.nih.gov/14506618","citation_count":16,"is_preprint":false},{"pmid":"30975032","id":"PMC_30975032","title":"INSM1 Expression in Peripheral Neuroblastic Tumors and Other Embryonal Neoplasms.","date":"2019","source":"Pediatric and developmental pathology : the official journal of the Society for Pediatric Pathology and the Paediatric Pathology Society","url":"https://pubmed.ncbi.nlm.nih.gov/30975032","citation_count":15,"is_preprint":false},{"pmid":"33025295","id":"PMC_33025295","title":"Insulinoma-associated protein 1 (INSM1) expression in breast carcinomas with neuroendocrine morphologies: application and future prospective.","date":"2020","source":"Virchows Archiv : an international journal of pathology","url":"https://pubmed.ncbi.nlm.nih.gov/33025295","citation_count":15,"is_preprint":false},{"pmid":"36305944","id":"PMC_36305944","title":"Insulinoma-associated-1 (INSM1) expression in thymic squamous cell carcinoma.","date":"2022","source":"Virchows Archiv : an international journal of pathology","url":"https://pubmed.ncbi.nlm.nih.gov/36305944","citation_count":14,"is_preprint":false},{"pmid":"31876605","id":"PMC_31876605","title":"Insulinoma-associated Protein 1 (INSM1) Expression in Small Cell Neuroendocrine Carcinoma of the Urinary Tract.","date":"2020","source":"Applied immunohistochemistry & molecular morphology : AIMM","url":"https://pubmed.ncbi.nlm.nih.gov/31876605","citation_count":14,"is_preprint":false},{"pmid":"34086646","id":"PMC_34086646","title":"Utility of Insulinoma-Associated Protein 1 (INSM1) and Mucin 2 (MUC2) Immunohistochemistry in the Distinction of Endocrine Mucin-Producing Sweat Gland Carcinoma From Morphologic Mimics.","date":"2022","source":"The American Journal of dermatopathology","url":"https://pubmed.ncbi.nlm.nih.gov/34086646","citation_count":14,"is_preprint":false},{"pmid":"33515627","id":"PMC_33515627","title":"Next-generation sequencing analysis suggests varied multistep mutational pathogenesis for endocrine mucin-producing sweat gland carcinoma with comments on INSM1 and MUC2 suggesting a conjunctival origin.","date":"2021","source":"Journal of the American Academy of Dermatology","url":"https://pubmed.ncbi.nlm.nih.gov/33515627","citation_count":14,"is_preprint":false},{"pmid":"34021851","id":"PMC_34021851","title":"Insulinoma-associated protein 1(INSM1) is a superior marker for the diagnosis of gastroenteropancreatic neuroendoerine neoplasms: a meta-analysis.","date":"2021","source":"Endocrine","url":"https://pubmed.ncbi.nlm.nih.gov/34021851","citation_count":13,"is_preprint":false},{"pmid":"35690220","id":"PMC_35690220","title":"Expression of novel neuroendocrine markers in breast carcinomas: a study of INSM1, ASCL1, and POU2F3.","date":"2022","source":"Human pathology","url":"https://pubmed.ncbi.nlm.nih.gov/35690220","citation_count":13,"is_preprint":false},{"pmid":"37951531","id":"PMC_37951531","title":"Comparison of INSM1 immunostaining with established neuroendocrine markers synaptophysin and chromogranin A in over 14,000 neuroendocrine and non-neuroendocrine tumors.","date":"2023","source":"Molecular and cellular endocrinology","url":"https://pubmed.ncbi.nlm.nih.gov/37951531","citation_count":13,"is_preprint":false},{"pmid":"19604042","id":"PMC_19604042","title":"INSM1 promoter-driven adenoviral herpes simplex virus thymidine kinase cancer gene therapy for the treatment of primitive neuroectodermal tumors.","date":"2009","source":"Human gene therapy","url":"https://pubmed.ncbi.nlm.nih.gov/19604042","citation_count":13,"is_preprint":false},{"pmid":"32745280","id":"PMC_32745280","title":"Comparative performance of insulinoma-associated protein 1 (INSM1) and routine immunohistochemical markers of neuroendocrine differentiation in the diagnosis of endocrine mucin-producing sweat gland carcinoma.","date":"2020","source":"Journal of cutaneous pathology","url":"https://pubmed.ncbi.nlm.nih.gov/32745280","citation_count":13,"is_preprint":false},{"pmid":"24977742","id":"PMC_24977742","title":"Fascin expression in cervical normal squamous epithelium, cervical intraepithelial neoplasia, and superficially invasive (stage IA1) squamous carcinoma of the cervix.","date":"2014","source":"Pathology","url":"https://pubmed.ncbi.nlm.nih.gov/24977742","citation_count":13,"is_preprint":false},{"pmid":"18627098","id":"PMC_18627098","title":"Xenopus zinc finger transcription factor IA1 (Insm1) expression marks anteroventral noradrenergic neuron progenitors in Xenopus embryos.","date":"2008","source":"Developmental dynamics : an official publication of the American Association of Anatomists","url":"https://pubmed.ncbi.nlm.nih.gov/18627098","citation_count":13,"is_preprint":false},{"pmid":"1714402","id":"PMC_1714402","title":"Electron microscopic identification of the intracellular secretion pathway of human G-CSF in a human tumor cell line: a comparative study with a Chinese hamster ovary cell line (IA1-7) transfected with human G-CSF cDNA.","date":"1991","source":"Experimental hematology","url":"https://pubmed.ncbi.nlm.nih.gov/1714402","citation_count":13,"is_preprint":false},{"pmid":"20332471","id":"PMC_20332471","title":"Repeat surgery in patients with cervical cancer stage FIGO IA1: a series of 156 cases and a review of the literature.","date":"2010","source":"Anticancer research","url":"https://pubmed.ncbi.nlm.nih.gov/20332471","citation_count":13,"is_preprint":false},{"pmid":"37990032","id":"PMC_37990032","title":"Insm1 regulates mTEC development and immune tolerance.","date":"2023","source":"Cellular & molecular immunology","url":"https://pubmed.ncbi.nlm.nih.gov/37990032","citation_count":12,"is_preprint":false},{"pmid":"33650906","id":"PMC_33650906","title":"Diagnostic Utility of INSM1 in Medullary Thyroid Carcinoma.","date":"2021","source":"International journal of surgical pathology","url":"https://pubmed.ncbi.nlm.nih.gov/33650906","citation_count":12,"is_preprint":false},{"pmid":"33210141","id":"PMC_33210141","title":"INSM1 Expression in Angiosarcoma.","date":"2021","source":"American journal of clinical pathology","url":"https://pubmed.ncbi.nlm.nih.gov/33210141","citation_count":11,"is_preprint":false}],"cost":{"stage1":{"model":"claude-sonnet-4-6","input_tokens":55077,"output_tokens":8585,"usd":0.147003,"stage1_stop_reason":"end_turn"},"stage2":{"model":"claude-opus-4-8","input_tokens":18211,"output_tokens":5765,"usd":0.11759,"stage2_stop_reason":"end_turn"},"total_usd":0.264593,"stage1_batch_id":"msgbatch_01DUPACZi7AAWwuZiUjseQF4","stage2_batch_id":"msgbatch_018yt7chE3f48PEFtDwtj6AE","note":"batch pricing = 50% of standard"},"stage1_raw":"```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 1992,\n      \"finding\": \"IA-1/INSM1 encodes a 510 amino acid protein with five C2H2 zinc-finger DNA-binding motifs in the C-terminal domain (aa 251-510) and a putative prohormone domain with dibasic conversion sites in the N-terminal domain (aa 1-250), establishing its basic domain architecture.\",\n      \"method\": \"cDNA cloning, sequence analysis, structural domain prediction\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — original cloning paper with full sequence analysis and domain mapping, foundational result replicated across subsequent studies\",\n      \"pmids\": [\"1634555\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1994,\n      \"finding\": \"The IA-1/INSM1 gene is intronless; both cDNA and genomic DNA yielded identical ~61 kDa protein products in in vitro translation, and the gene was chromosomally localized to the short arm of human chromosome 20.\",\n      \"method\": \"Genomic cloning, restriction mapping, sequencing, in vitro translation, in situ hybridization\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — direct experimental demonstration with in vitro translation and genomic sequencing, foundational structural characterization\",\n      \"pmids\": [\"8188699\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2002,\n      \"finding\": \"INSM1/IA-1 functions as a transcriptional repressor; the repressor activity resides predominantly in amino acids 168–263. Using SELEX with bacterially expressed GST-IA-1DBD, the consensus DNA-binding sequence was identified as TG/TC/TC/TT/AGGGGG/TCG/A, and zinc fingers 2 and 3 are sufficient for transcriptional activity. INSM1 can auto-regulate its own promoter and repress the NeuroD/beta2 promoter.\",\n      \"method\": \"GAL4-DBD fusion reporter assays, SELEX/random oligonucleotide binding, GST pulldown, co-transfection reporter assays, mutagenesis\",\n      \"journal\": \"Nucleic acids research\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — multiple orthogonal methods (SELEX, mutagenesis, reporter assays) in a single rigorous study establishing repressor function and consensus binding site\",\n      \"pmids\": [\"11842116\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2002,\n      \"finding\": \"INSM1 protein localizes exclusively to the nucleus when expressed in transfected cells. INSM1 interacts with Cbl-associated protein (CAP); this interaction was confirmed by yeast two-hybrid, in vitro pulldown, nuclear co-localization, and co-immunoprecipitation, with both proteins detected in the nucleus of insulinoma cells.\",\n      \"method\": \"GFP-INSM1 transfection/fluorescence microscopy, yeast two-hybrid screen, in vitro pulldown, co-immunoprecipitation\",\n      \"journal\": \"Genomics\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — reciprocal Co-IP and multiple orthogonal methods confirming INSM1-CAP interaction and nuclear localization\",\n      \"pmids\": [\"12079283\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2003,\n      \"finding\": \"The NeuroD1/E47 heterodimer directly binds the proximal E-box (E3) element of the IA-1 promoter and activates IA-1 transcription; the E3 box (−426 to −65 bp region) is critical for tissue-specific promoter activity.\",\n      \"method\": \"Promoter deletion reporter constructs, EMSA, transient transfection, mutagenesis\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — EMSA plus mutagenesis plus reporter assays defining the critical cis-element and trans-activating complex\",\n      \"pmids\": [\"12890672\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2006,\n      \"finding\": \"INSM1 functions as a transcriptional repressor of the NeuroD/beta2 gene by recruiting cyclin D1 and histone deacetylases (HDAC-1 and HDAC-3). Cyclin D1 was identified as an INSM1-interacting protein via yeast two-hybrid from a human fetal brain library; the interaction was confirmed by in vitro and in vivo pulldown. INSM1 forms a complex with cyclin D1 and HDAC-3 on the NeuroD/beta2 promoter, as confirmed by chromatin immunoprecipitation.\",\n      \"method\": \"Yeast two-hybrid, in vitro pulldown, co-immunoprecipitation, chromatin immunoprecipitation (ChIP), reporter gene assays\",\n      \"journal\": \"The Biochemical journal\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 / Strong — multiple orthogonal methods (yeast two-hybrid, Co-IP, ChIP, reporter assays) establishing the INSM1–cyclin D1–HDAC repressor complex\",\n      \"pmids\": [\"16569215\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2006,\n      \"finding\": \"Insm1 is essential for the development of pancreatic beta cells and intestinal endocrine cells. In Insm1 mutant mice, endocrine precursors form but fail to differentiate into hormone-positive cells; many genes encoding secretory machinery proteins are down-regulated. Insm1 thus controls a gene expression program comprising hormones and proteins of the secretory machinery.\",\n      \"method\": \"Insm1 knockout mouse, histology, immunohistochemistry, gene expression analysis\",\n      \"journal\": \"Genes & development\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — genetic loss-of-function in mice with defined cellular phenotype and gene expression readout, widely replicated\",\n      \"pmids\": [\"16951258\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2006,\n      \"finding\": \"IA1/INSM1 is a direct transcriptional target of Ngn3 in the embryonic pancreas. Ngn3 binds to chromatin at the IA1 promoter region and activates IA1 transcription. IA1 expression is absent in Ngn3-null embryos but is normal in embryos mutant for NeuroD1, Arx, Pax4, and Pax6 (factors downstream of Ngn3), placing IA1 immediately downstream of Ngn3 in the endocrinogenic transcription factor network.\",\n      \"method\": \"Chromatin immunoprecipitation, ectopic expression in adult pancreatic duct cells, mouse mutant analysis (epistasis)\",\n      \"journal\": \"The EMBO journal\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 / Strong — ChIP demonstrating direct Ngn3 binding, confirmed by epistasis in multiple mutant backgrounds\",\n      \"pmids\": [\"16511571\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2007,\n      \"finding\": \"Neurogenin 3 (Ngn3) and its co-activator CBP occupy the INSM1 promoter, leading to hyper-acetylation of histone H3/H4 in the INSM1 promoter region; adenoviral Ngn3 induces endogenous INSM1 expression in pancreatic ductal cells through CBP recruitment.\",\n      \"method\": \"Chromatin immunoprecipitation (ChIP) for endogenous Ngn3 and CBP at INSM1 promoter, adenoviral overexpression, histone acetylation assay\",\n      \"journal\": \"FEBS letters\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 / Strong — direct ChIP evidence for CBP co-activator recruitment and histone acetylation at the INSM1 locus\",\n      \"pmids\": [\"17300785\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2007,\n      \"finding\": \"Insm1 is an essential component of the transcriptional network controlling sympatho-adrenal lineage differentiation. In Insm1 mutant mice, differentiation of sympatho-adrenal precursors is delayed, accompanied by reduced proliferation; terminal differentiation of adrenal chromaffin cells is blocked. The transcription factors Mash1, Phox2a, Gata3, and Hand2 show deregulated expression in Insm1 mutants, indicating Insm1 acts downstream of Mash1 (Ascl1) in this network. Fetal lethality of Insm1 mutants is caused by catecholamine deficiency.\",\n      \"method\": \"Insm1 knockout mouse, gene expression analysis, epistasis/genetic interaction analysis\",\n      \"journal\": \"Development (Cambridge, England)\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — genetic loss-of-function with epistatic placement in transcriptional network, defined lethality mechanism\",\n      \"pmids\": [\"18094025\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2008,\n      \"finding\": \"INSM1 protein is expressed exclusively in the nuclei of late neuronal progenitors and nascent (but not mature) neurons throughout embryonic and adult neurogenesis; non-surface (basal/subventricular zone) progenitors express INSM1, whereas apically mitotic progenitors do not, paralleling the role of the C. elegans ortholog EGL-46 in terminal neurogenic divisions.\",\n      \"method\": \"In situ hybridization combined with immunohistochemistry in mouse and human embryos; cellular localization across multiple neurogenic regions\",\n      \"journal\": \"The Journal of comparative neurology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — direct localization experiments with functional inference; single study\",\n      \"pmids\": [\"18205207\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2008,\n      \"finding\": \"INSM1 binds a specific site in the proximal insulin promoter and represses insulin gene transcription by approximately 50%. Repression is mediated by recruitment of cyclin D1 and HDAC-3 to the insulin promoter. ChIP in beta TC-1 cells, mouse fetal pancreas, and Ad-INSM1-transduced human islets confirmed endogenous INSM1 occupancy of the insulin promoter. Morpholino knockdown of INSM1 or cyclin D1 in fetal mouse pancreas enhances insulin promoter activity.\",\n      \"method\": \"Reporter gene assays with mutagenesis, ChIP, co-immunoprecipitation, morpholino knockdown\",\n      \"journal\": \"The Journal of endocrinology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 / Strong — multiple orthogonal methods (ChIP, mutagenesis, morpholino KD, reporter assays) in multiple cell systems\",\n      \"pmids\": [\"18417529\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2008,\n      \"finding\": \"Insm1 is regulated downstream of Sonic Hedgehog signaling and is expressed in developing cerebellum granule cell progenitors; Insm1 and Nhlh1 are novel HH targets induced by Shh treatment in cultured cerebellar granule cell progenitors, and their expression is upregulated in HH-dependent medulloblastomas.\",\n      \"method\": \"Gene expression profiling, Shh treatment of cultured progenitors, Gli1 binding to Nhlh1 promoter\",\n      \"journal\": \"Neoplasia (New York, N.Y.)\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — direct Shh treatment experiment plus promoter binding, single lab\",\n      \"pmids\": [\"18231642\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2009,\n      \"finding\": \"INSM1 binds directly to cyclin D1 via the cyclin box domain; the proline-rich N-terminal region of INSM1 is required for this binding. INSM1 binding to cyclin D1 disrupts cyclin D1–CDK4 association, induces hypophosphorylation of pRb, and causes cell cycle arrest. Mutation of proline residues abolishes cyclin D1 binding and abrogates cell cycle arrest. INSM1 overexpression inhibits proliferation of Panc-1 cells in vitro and in nude mouse tumor models.\",\n      \"method\": \"Competitive pulldown, co-immunoprecipitation, Tet-on inducible expression system, cell cycle synchronization, serum starvation, MTT assay, soft agar colony formation, nude mouse xenograft, mutagenesis\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — direct biochemical reconstitution of the INSM1–cyclin D1 interaction, mutagenesis, and multiple functional readouts including in vivo\",\n      \"pmids\": [\"19124461\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2009,\n      \"finding\": \"Insm1 is essential for the differentiation of serotonergic and noradrenergic neurons in the hindbrain. A conserved cis-regulatory sequence of Insm1 is directly bound and activated by Ascl1 in the ventral hindbrain. In Insm1-null mice, serotonergic fate determinants Pet1, Lmx1b, and Gata2 are markedly downregulated; Tph2 (tryptophan hydroxylase 2, key serotonin biosynthesis enzyme) fails to be activated. Both Insm1 and Ascl1 coordinately specify Tph2 expression. In brainstem noradrenergic centers, tyrosine hydroxylase expression is delayed/deficient in Insm1 mutants.\",\n      \"method\": \"Insm1-null mouse genetics, Ascl1 chromatin occupancy (ChIP at Insm1 regulatory element), epistatic analysis of downstream transcription factors\",\n      \"journal\": \"Development (Cambridge, England)\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — genetic loss-of-function plus ChIP for Ascl1 at Insm1 locus, well-defined phenotypic readouts\",\n      \"pmids\": [\"19542360\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2011,\n      \"finding\": \"Insm1 promotes the transition of olfactory progenitors from apical/proliferative to basal/terminally-dividing and neuronogenic. Deletion of Insm1 in mice results in more apical progenitors expressing ASCL1, fewer basal/NEUROD1-expressing terminal progenitors, and fewer terminally dividing cells (confirmed by nucleoside analog pulse-chase). This role is partially conserved with the C. elegans ortholog egl-46.\",\n      \"method\": \"Insm1 knockout mouse, immunohistochemistry, nucleoside analog (BrdU/EdU) pulse-chase for cell division timing\",\n      \"journal\": \"Neural development\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — genetic KO with defined progenitor pool quantification using orthogonal markers and pulse-chase\",\n      \"pmids\": [\"21284846\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2013,\n      \"finding\": \"Insm1 requires its N-terminal SNAG domain for function in vivo. The SNAG domain recruits histone-modifying factors including Kdm1a (LSD1), Hdac1/2, Rcor1-3, and other transcriptional regulators (Hmg20a/b, Gse1). Deletion of the SNAG domain in mice disrupted pituitary endocrine cell differentiation and caused upregulation of Notch pathway components and ectopic skeletal muscle gene expression, phenocopying full Insm1 deletion in the pituitary.\",\n      \"method\": \"SNAG domain deletion mouse model, mass spectrometry of Insm1 co-purifying proteins, co-immunoprecipitation, gene expression analysis\",\n      \"journal\": \"Development (Cambridge, England)\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 / Strong — domain deletion in vivo plus MS identification of co-purifying histone-modifying complexes\",\n      \"pmids\": [\"24227653\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2014,\n      \"finding\": \"INSM1 interacts with RACK1 through its proline-rich N-terminal region; this interaction disrupts RACK1–insulin receptor (InR) binding, enhancing InR-mediated signaling and increasing AKT phosphorylation. INSM1-enhanced AKT phosphorylation is blocked by the PI3K inhibitor LY294002. The INSM1/RACK1/InR pathway activates Nkx6.1 expression via increased acetyl-H4 modification of the Nkx6.1 promoter during AR42J cell trans-differentiation.\",\n      \"method\": \"Co-immunoprecipitation, competitive binding assay, phospho-AKT western blot, PI3K inhibitor treatment, ChIP for histone acetylation at Nkx6.1 promoter\",\n      \"journal\": \"Cellular signalling\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — Co-IP plus pharmacological inhibition plus ChIP, single lab\",\n      \"pmids\": [\"24407176\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2014,\n      \"finding\": \"Insm1 promotes the transition from ductal progenitor to committed endocrine cell in the pancreas by repressing a progenitor cell program and activating genes for RNA splicing, cell migration, cell proliferation, and hormone secretion. Insm1 positively regulates Neurog3 (reducing a non-coding Neurog3 mRNA splice variant in its absence), and regulates the proliferation inhibitor Ripply3.\",\n      \"method\": \"Insm1(GFPCre) reporter allele, flow-cytometry cell sorting, transcriptome analysis of Insm1-null populations, genetic analysis of Ripply3 function\",\n      \"journal\": \"Development (Cambridge, England)\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — genetic reporter allele, FACS-sorted cell population transcriptomics, functional analysis of downstream target\",\n      \"pmids\": [\"25053427\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2015,\n      \"finding\": \"Insm1 directly interacts with Neurod1 and Foxa2, and this trimeric complex binds regulatory sequences in the genome of mature pancreatic beta cells. Ablation of Insm1 in mature beta cells causes deficits in insulin secretion; adult mutant beta cells resemble immature neonatal beta cells in gene expression. Combinatorial Insm1/Neurod1/Foxa2 binding—not Insm1 binding alone—explains the majority of gene expression changes.\",\n      \"method\": \"Conditional Insm1 ablation in adult beta cells, Co-immunoprecipitation, ChIP-seq for all three factors, gene expression analysis, functional insulin secretion assay\",\n      \"journal\": \"The EMBO journal\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 / Strong — ChIP-seq plus Co-IP plus conditional KO plus functional insulin secretion readout in a single study\",\n      \"pmids\": [\"25828096\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2015,\n      \"finding\": \"Insm1 is expressed downstream of Ascl1 in pulmonary neuroendocrine cells (Insm1 expression is absent in Ascl1-mutant lungs). Insm1 directly binds the Hes1 promoter and represses Hes1 expression; this Insm1-dependent Hes1 repression is required for neuroendocrine cell differentiation in the lung. Loss of Insm1 blocks terminal differentiation and upregulates Hes1 protein in neuroendocrine cells while interfering with Ascl1 maintenance.\",\n      \"method\": \"Ascl1 mutant mouse epistasis, Insm1 knockout mouse, ChIP for Insm1 on Hes1 promoter, immunohistochemistry, gene expression analysis\",\n      \"journal\": \"Developmental biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 / Strong — ChIP demonstrating direct Insm1 binding to Hes1 promoter, confirmed by genetic epistasis and KO phenotype\",\n      \"pmids\": [\"26453796\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2015,\n      \"finding\": \"INSM1 increases N-myc stability in neuroblastoma by activating the PI3K/AKT/GSK3β pathway, suppressing N-myc phosphorylation at Thr-58 and thereby inhibiting N-myc degradation. N-myc in turn binds the E2-box of the INSM1 promoter and activates INSM1 expression, forming a positive-feedback loop. The Sonic hedgehog pathway induces this loop.\",\n      \"method\": \"Overexpression and knockdown in neuroblastoma cells, PI3K/AKT pathway inhibition, phospho-N-myc western blot, ChIP for N-myc at INSM1 promoter, invasion assay, xenograft nude mouse model\",\n      \"journal\": \"Oncotarget\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — ChIP plus signaling pathway analysis plus in vivo xenograft, single lab\",\n      \"pmids\": [\"26456864\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2017,\n      \"finding\": \"INSM1 interacts with LSD1 (KDM1A) via its SNAG domain, and this interaction is required for neuroendocrine-associated gene expression and SCLC cell proliferation. The irreversible LSD1 inhibitor T-3775440 disrupts the LSD1–INSM1 interaction, inhibiting expression of neuroendocrine genes such as ASCL1 and reducing SCLC proliferation. INSM1 silencing phenocopies T-3775440 effects on gene expression and proliferation.\",\n      \"method\": \"Co-immunoprecipitation (LSD1–INSM1), LSD1 inhibitor treatment, INSM1 siRNA knockdown, gene expression analysis, in vitro and in vivo proliferation assays\",\n      \"journal\": \"Cancer research\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — direct Co-IP demonstrating LSD1–INSM1 complex, pharmacological disruption, and genetic phenocopy by INSM1 silencing\",\n      \"pmids\": [\"28667074\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2017,\n      \"finding\": \"INSM1 forms complexes with REST corepressors RCOR1 and RCOR2 in embryonic mouse brain progenitors. The Insm1-/- mouse phenocopies predominant brain phenotypes of the Rcor1/2 double knockout, including abnormally high neural progenitor numbers, fewer differentiated neurons/OPC, and defective interganglionic sulcus closure. A large number of genes are concordantly misregulated in both knockouts, and REST transcripts are upregulated in both; reducing REST to control levels in the Rcor1/2 KO partially rescues the interganglionic sulcus defect.\",\n      \"method\": \"Co-immunoprecipitation (INSM1–RCOR1/2 in embryonic brain), double-knockout mouse genetics, transcriptome analysis, REST rescue experiment\",\n      \"journal\": \"Proceedings of the National Academy of Sciences of the United States of America\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — Co-IP plus genetic epistasis (phenocopy and rescue) plus transcriptome comparison across two knockout genotypes\",\n      \"pmids\": [\"28049845\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2018,\n      \"finding\": \"Insm1 is transiently expressed in nascent outer hair cells (OHCs) but not inner hair cells (IHCs). In the absence of INSM1, many OHCs trans-differentiate into IHCs: INSM1 represses a core set of IHC-enriched genes in embryonic OHCs, rendering them unresponsive to an IHC-inducing gradient. Upregulation of IHC-enriched genes in INSM1-deficient OHCs identifies candidate genes for IHC-specific differentiation.\",\n      \"method\": \"Insm1 conditional knockout mouse, transcriptome comparison of immature IHCs vs OHCs with/without INSM1, immunohistochemistry, electrophysiology\",\n      \"journal\": \"Nature\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — genetic KO with transcriptome analysis and functional cell-type transformation, published in Nature with multiple orthogonal methods\",\n      \"pmids\": [\"30305733\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2018,\n      \"finding\": \"Insm1 promotes delamination of neural progenitor cells (NPCs) from the ventricular surface during neocortex development by repressing Plekha7, an apical adherens junction belt-specific protein. Forced Insm1 expression converts apical to basal radial glia. CRISPR/Cas9 disruption of Plekha7 alone causes NPC delamination, and Plekha7 overexpression counteracts Insm1-induced delamination.\",\n      \"method\": \"In utero electroporation of Insm1, CRISPR/Cas9 knockout of Plekha7, Plekha7 overexpression rescue, live imaging, immunostaining\",\n      \"journal\": \"Neuron\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 / Strong — gain-of-function, CRISPR loss-of-function, and rescue experiments establishing the Insm1→Plekha7→delamination pathway\",\n      \"pmids\": [\"29503187\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2018,\n      \"finding\": \"The Sonic hedgehog signaling pathway activates INSM1 expression in SCLC through N-myc and Ascl1, both of which bind the E2-box in the INSM1 promoter. INSM1 in turn crosstalks with the Shh-PI3K/AKT-N-myc/Ascl1-MEK/ERK1/2 transcriptional network, enhancing N-myc stability. Knockdown of INSM1 or Shh inhibitors reduce NE lung cancer cell growth.\",\n      \"method\": \"Promoter reporter assays, ChIP for N-myc and Ascl1 at INSM1 E2-box, INSM1 knockdown, Shh inhibitor treatment, western blot for N-myc stability\",\n      \"journal\": \"Cellular signalling\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — ChIP plus reporter assays plus knockdown, single lab\",\n      \"pmids\": [\"29501727\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"Insm1 expression determines the phenotype of pancreatic neuroendocrine tumors in the RIP1-Tag2 mouse model: high Insm1 expression correlates with insulinoma (localized, hormone-secreting), while loss of Insm1 correlates with nonfunctioning metastatic PanNETs. In human cell lines, Insm1-deficient cells express stem cell markers, are more invasive in vitro, and metastasize at higher rates in vivo. INSM1 promoter is hypermethylated in human nonfunctioning PanNETs.\",\n      \"method\": \"Mouse genetic crosses (RIP1-Tag2), Insm1 KO cell lines, in vitro invasion assay, in vivo metastasis assay, promoter methylation analysis\",\n      \"journal\": \"Oncogenesis\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — combined genetic mouse model and cell-line KO with in vivo metastasis readout, single lab\",\n      \"pmids\": [\"30796198\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2021,\n      \"finding\": \"Cross-talk among MEN1, p53, and Notch signaling regulates INSM1 expression and subcellular localization in pancreatic neuroendocrine tumor cells. Loss of MEN1 in a p53 wild-type background results in increased nuclear INSM1 expression and cell proliferation. Inhibition of Notch signaling in a p53 wild-type background reduces PanNET cell proliferation by repressing INSM1 transcription and nuclear localization.\",\n      \"method\": \"PanNET mouse model, human cell lines, human tissue analysis, INSM1 localization by immunostaining, Notch inhibitor treatment, MEN1/p53 genetic manipulation\",\n      \"journal\": \"Neoplasia (New York, N.Y.)\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — combination of mouse model, cell lines, and human tissue with functional inhibition experiments; single lab\",\n      \"pmids\": [\"34352404\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2023,\n      \"finding\": \"Epistasis analysis in cochlear hair cells reveals that Insm1 acts as a positive (but indirect) regulator of Ikzf2: Insm1 overexpression in IHCs leads to ectopic Ikzf2 expression; Ikzf2 expression is repressed in Insm1-deficient OHCs; forced Ikzf2 expression partially rescues OHC abnormalities in Insm1 mutants; and dual ablation of Insm1 and Ikzf2 produces the same OHC-to-IHC transdifferentiation phenotype as Insm1 ablation alone. This establishes a transcriptional cascade from Insm1 to Ikzf2 in OHC development.\",\n      \"method\": \"Insm1 overexpression in IHCs, Insm1 conditional KO, Ikzf2 conditional KO, Insm1/Ikzf2 double KO, Ikzf2 forced expression rescue, immunostaining\",\n      \"journal\": \"Cell reports\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — genetic epistasis established by gain-of-function, loss-of-function, rescue, and double-KO experiments in the same tissue system\",\n      \"pmids\": [\"37171961\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2023,\n      \"finding\": \"Insm1 is broadly co-expressed with Aire in medullary thymic epithelial cells (mTECs). Insm1 mutation in mice downregulates Aire expression, dysregulates the mTEC gene expression program, alters mTEC subpopulations and tissue-restricted antigen expression, and causes autoimmune responses in peripheral tissues. Insm1 regulates gene expression in mTECs by direct chromatin binding; the majority of Insm1 binding sites are co-occupied by Aire and enriched in superenhancer regions.\",\n      \"method\": \"Insm1 mutant mouse, immunostaining, transcriptome analysis of mTECs, ChIP for Insm1 in mTECs, autoimmune phenotype assessment\",\n      \"journal\": \"Cellular & molecular immunology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — direct ChIP in mTECs plus genetic KO with autoimmune phenotype, co-occupancy with Aire at superenhancers\",\n      \"pmids\": [\"37990032\"],\n      \"is_preprint\": false\n    }\n  ],\n  \"current_model\": \"INSM1 is a nuclear zinc-finger transcriptional repressor (using a SNAG domain to recruit LSD1/HDAC/CoREST complexes and cyclin D1) that acts downstream of proneural factors (Ngn3, Ascl1) to drive terminal differentiation of neuroendocrine, neuronal, and sensory hair cell lineages by repressing progenitor/alternative-fate gene programs, inhibiting cell cycle progression through disruption of cyclin D1–CDK4 complexes, and participating in combinatorial transcription factor complexes (e.g., with Neurod1 and Foxa2) to maintain mature endocrine cell identity.\"\n}\n```","stage2_raw":"{\n  \"mechanistic_narrative\": \"INSM1 is a nuclear C2H2 zinc-finger transcription factor that acts downstream of proneural factors (Ngn3, Ascl1/Mash1) to drive terminal differentiation of neuroendocrine, neuronal, and sensory lineages by repressing progenitor and alternative-fate gene programs [#6, #7, #9, #14, #20]. Its architecture combines an N-terminal regulatory/SNAG region with five C-terminal zinc fingers that bind a defined consensus DNA element and confer transcriptional repression [#0, #2]. As a target of Ngn3/CBP and Ascl1, which bind and activate the INSM1 promoter/regulatory elements, INSM1 is induced at the progenitor-to-differentiated transition and can autoregulate its own promoter [#2, #7, #8, #14]. Repression is executed through its SNAG domain, which recruits histone-modifying complexes including LSD1 (KDM1A), HDAC1/2, and the REST corepressors RCOR1-3, and through recruitment of cyclin D1 and HDAC-3 to target promoters such as insulin and NeuroD/beta2 [#5, #11, #16, #22, #23]. Beyond transcriptional repression, INSM1 binds cyclin D1 via its proline-rich N-terminus, disrupting cyclin D1\\u2013CDK4 association, causing pRb hypophosphorylation and cell-cycle arrest [#13]. In mature endocrine cells INSM1 partners combinatorially with Neurod1 and Foxa2 to maintain differentiated identity and insulin secretion [#19]. Loss of INSM1 produces failures or switches of cell fate across tissues\\u2014blocked endocrine, chromaffin, serotonergic/noradrenergic, and pulmonary neuroendocrine differentiation, transdifferentiation of outer to inner cochlear hair cells, retention of apical/proliferative progenitors, and autoimmune dysregulation in thymic epithelium [#6, #9, #14, #15, #20, #24, #30]. INSM1 is also embedded in oncogenic neuroendocrine circuits, supporting SCLC and neuroblastoma proliferation and modulating pancreatic neuroendocrine tumor phenotype [#21, #22, #27].\",\n  \"teleology\": [\n    {\n      \"year\": 1992,\n      \"claim\": \"Defining the protein's domain architecture established INSM1 as a candidate DNA-binding factor, framing all subsequent functional study.\",\n      \"evidence\": \"cDNA cloning and sequence/domain prediction identifying five C2H2 zinc fingers and an N-terminal putative prohormone region\",\n      \"pmids\": [\"1634555\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"No DNA target or transcriptional activity demonstrated\", \"Functional role of the N-terminal domain unresolved\"]\n    },\n    {\n      \"year\": 1994,\n      \"claim\": \"Showing the gene is intronless and maps to chromosome 20p completed its basic structural characterization.\",\n      \"evidence\": \"Genomic cloning, in vitro translation, and in situ hybridization\",\n      \"pmids\": [\"8188699\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Does not address regulation or function\", \"No cellular phenotype examined\"]\n    },\n    {\n      \"year\": 2002,\n      \"claim\": \"Establishing INSM1 as a sequence-specific transcriptional repressor with a defined consensus site, autoregulation, and nuclear localization converted it from a sequence to a functional regulator and revealed an early interaction with CAP.\",\n      \"evidence\": \"GAL4 reporter and SELEX with GST-DBD, mutagenesis, plus yeast two-hybrid/Co-IP and GFP localization\",\n      \"pmids\": [\"11842116\", \"12079283\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Mechanism of repression (corepressors) not yet identified\", \"Functional significance of the CAP interaction unclear\"]\n    },\n    {\n      \"year\": 2003,\n      \"claim\": \"Identifying the NeuroD1/E47-bound E-box in the INSM1 promoter placed INSM1 within an endocrine transcription factor hierarchy as a transcriptional target.\",\n      \"evidence\": \"Promoter deletion reporters, EMSA, and mutagenesis\",\n      \"pmids\": [\"12890672\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"In vivo relevance of the E3 element not tested at this stage\"]\n    },\n    {\n      \"year\": 2006,\n      \"claim\": \"Positioning INSM1 immediately downstream of Ngn3 and demonstrating it is essential for endocrine cell differentiation defined its core developmental role and its repressor mechanism via cyclin D1/HDAC recruitment.\",\n      \"evidence\": \"Ngn3-null epistasis and ChIP, Insm1 knockout mouse phenotyping, and ChIP/yeast two-hybrid/Co-IP for the cyclin D1\\u2013HDAC complex on NeuroD/beta2\",\n      \"pmids\": [\"16511571\", \"16951258\", \"16569215\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Genome-wide target repertoire not defined\", \"Direct versus indirect target distinction limited to candidate promoters\"]\n    },\n    {\n      \"year\": 2007,\n      \"claim\": \"Demonstrating Ngn3/CBP occupancy and histone hyperacetylation at the INSM1 promoter clarified how the upstream proneural factor activates INSM1 transcription.\",\n      \"evidence\": \"ChIP for Ngn3 and CBP, adenoviral overexpression, and histone acetylation assays\",\n      \"pmids\": [\"17300785\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Does not address downstream INSM1 targets\"]\n    },\n    {\n      \"year\": 2007,\n      \"claim\": \"Extending INSM1 function to sympatho-adrenal differentiation placed it downstream of Mash1/Ascl1 and tied its loss to catecholamine-deficiency lethality.\",\n      \"evidence\": \"Insm1 knockout mouse with gene-expression and epistasis analysis\",\n      \"pmids\": [\"18094025\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Direct INSM1 target genes in this lineage not identified\"]\n    },\n    {\n      \"year\": 2008,\n      \"claim\": \"Mapping INSM1 expression to late/basal neuronal progenitors and establishing direct repression of the insulin promoter via cyclin D1/HDAC-3 refined both where and how INSM1 acts.\",\n      \"evidence\": \"ISH/IHC localization across neurogenic zones; reporter mutagenesis, ChIP in multiple systems, and morpholino knockdown for insulin repression; plus Shh-induced expression in cerebellar progenitors\",\n      \"pmids\": [\"18205207\", \"18417529\", \"18231642\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Localization study single-lab and partly inferential\", \"Shh-to-INSM1 link correlative for cerebellar progenitors\"]\n    },\n    {\n      \"year\": 2009,\n      \"claim\": \"Biochemical reconstitution showed INSM1 binds cyclin D1 through its proline-rich N-terminus to disrupt cyclin D1\\u2013CDK4 and arrest the cell cycle, while genetics linked it to serotonergic/noradrenergic neuron differentiation downstream of Ascl1.\",\n      \"evidence\": \"Competitive pulldown, mutagenesis, Tet-on expression, xenografts; and Insm1-null mice with Ascl1 ChIP at the Insm1 regulatory element\",\n      \"pmids\": [\"19124461\", \"19542360\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"How cell-cycle and transcriptional-repressor functions are coordinated unresolved\", \"Direct serotonergic target promoters not all defined\"]\n    },\n    {\n      \"year\": 2011,\n      \"claim\": \"Showing INSM1 drives the apical-to-basal, proliferative-to-neuronogenic transition of olfactory progenitors connected its expression pattern to a concrete progenitor-transition function.\",\n      \"evidence\": \"Insm1 knockout mouse with marker analysis and nucleoside pulse-chase\",\n      \"pmids\": [\"21284846\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Molecular targets governing the transition not yet identified\"]\n    },\n    {\n      \"year\": 2013,\n      \"claim\": \"Identifying the SNAG domain as the in vivo functional module that recruits LSD1/HDAC/CoREST machinery provided the mechanistic basis of INSM1-mediated repression.\",\n      \"evidence\": \"SNAG-deletion mouse, mass spectrometry of co-purifying proteins, and Co-IP\",\n      \"pmids\": [\"24227653\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Stoichiometry and locus-specific composition of the complex not resolved\"]\n    },\n    {\n      \"year\": 2014,\n      \"claim\": \"Transcriptomics of sorted endocrine progenitors and a non-canonical RACK1/insulin-receptor signaling role broadened INSM1's mechanistic repertoire beyond classical repression.\",\n      \"evidence\": \"Insm1(GFPCre) reporter, FACS and transcriptome analysis of pancreatic populations; and Co-IP/competitive binding with RACK1/InR plus phospho-AKT and ChIP\",\n      \"pmids\": [\"25053427\", \"24407176\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"RACK1/InR signaling role is single-lab Medium-confidence\", \"Cytoplasmic versus nuclear partition of these functions unclear\"]\n    },\n    {\n      \"year\": 2015,\n      \"claim\": \"Defining a combinatorial Insm1/Neurod1/Foxa2 complex in mature beta cells and direct Hes1 repression in pulmonary neuroendocrine cells showed INSM1 maintains differentiated identity and antagonizes Notch effectors.\",\n      \"evidence\": \"Conditional beta-cell ablation with ChIP-seq/Co-IP and insulin-secretion assays; Ascl1-mutant epistasis with Insm1 ChIP at Hes1; plus N-myc positive-feedback work in neuroblastoma\",\n      \"pmids\": [\"25828096\", \"26453796\", \"26456864\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Genome-wide cooperativity rules between the three factors not fully defined\", \"N-myc feedback loop Medium-confidence single-lab\"]\n    },\n    {\n      \"year\": 2017,\n      \"claim\": \"Demonstrating direct SNAG-mediated LSD1 binding required for SCLC gene expression, and INSM1\\u2013RCOR1/2 complexes phenocopying Rcor1/2 knockouts in brain, solidified INSM1 as a recruiter of REST-corepressor/LSD1 machinery with therapeutic relevance.\",\n      \"evidence\": \"Co-IP, LSD1-inhibitor disruption and siRNA phenocopy in SCLC; Co-IP plus double-knockout genetics, transcriptomics, and REST rescue in embryonic brain\",\n      \"pmids\": [\"28667074\", \"28049845\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Locus selectivity of LSD1/RCOR recruitment not resolved\", \"How INSM1 represses REST itself unclear\"]\n    },\n    {\n      \"year\": 2018,\n      \"claim\": \"Three studies showed INSM1 enforces cell-fate decisions: repressing IHC genes in outer hair cells, repressing Plekha7 to drive neural progenitor delamination, and feeding into the Shh/N-myc/Ascl1 circuit in SCLC.\",\n      \"evidence\": \"Cochlear conditional KO with transcriptomics/electrophysiology; in utero electroporation with Plekha7 CRISPR KO and rescue; promoter/ChIP and knockdown in SCLC\",\n      \"pmids\": [\"30305733\", \"29503187\", \"29501727\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Direct INSM1 binding at all relevant fate-gene loci not exhaustively mapped\", \"SCLC Shh circuit Medium-confidence single-lab\"]\n    },\n    {\n      \"year\": 2019,\n      \"claim\": \"Linking INSM1 level to pancreatic neuroendocrine tumor phenotype connected its differentiation function to tumor aggressiveness and metastasis.\",\n      \"evidence\": \"RIP1-Tag2 mouse crosses, Insm1-KO cell lines, invasion/metastasis assays, and promoter methylation analysis\",\n      \"pmids\": [\"30796198\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Single-lab; mechanism connecting INSM1 loss to stemness/invasion not defined\", \"Causality of promoter hypermethylation not established\"]\n    },\n    {\n      \"year\": 2021,\n      \"claim\": \"Showing MEN1/p53/Notch crosstalk controls INSM1 expression and nuclear localization extended understanding of how INSM1 is regulated in tumor contexts.\",\n      \"evidence\": \"PanNET mouse/cell/tissue models with Notch inhibition and MEN1/p53 manipulation, INSM1 immunostaining\",\n      \"pmids\": [\"34352404\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Single-lab correlative regulation\", \"Direct molecular link from MEN1/p53/Notch to INSM1 promoter not defined\"]\n    },\n    {\n      \"year\": 2023,\n      \"claim\": \"Defining the Insm1\\u2192Ikzf2 cascade in cochlear hair cells and INSM1/Aire co-occupancy at superenhancers in thymic epithelium revealed lineage-specific downstream targets and a new immunological role.\",\n      \"evidence\": \"Cochlear gain/loss/double-KO/rescue genetics; and Insm1-mutant mice with mTEC transcriptomics, Insm1 ChIP, and autoimmune phenotyping\",\n      \"pmids\": [\"37171961\", \"37990032\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether Insm1 regulates Ikzf2 directly remains unresolved (indirect regulator)\", \"Mechanism of INSM1\\u2013Aire co-regulation at superenhancers not detailed\"]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"How INSM1 selects specific target loci across diverse lineages, and how its transcriptional-repressor and cyclin D1/cell-cycle functions are integrated, remains unresolved.\",\n      \"evidence\": \"No single study reconciles locus-selective corepressor recruitment with the cell-cycle-arrest mechanism across tissues\",\n      \"pmids\": [],\n      \"confidence\": \"Low\",\n      \"gaps\": [\"No unified model of context-specific target selection\", \"Structural basis of zinc-finger DNA recognition in vivo not determined\", \"Integration of nuclear repressor and cytoplasmic signaling roles unclear\"]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0140110\", \"supporting_discovery_ids\": [2, 5, 11, 19, 20]},\n      {\"term_id\": \"GO:0003677\", \"supporting_discovery_ids\": [2, 20, 30]},\n      {\"term_id\": \"GO:0098772\", \"supporting_discovery_ids\": [13, 16, 22]},\n      {\"term_id\": \"GO:0060090\", \"supporting_discovery_ids\": [16, 19, 23]}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0005634\", \"supporting_discovery_ids\": [3, 10, 28]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"R-HSA-1266738\", \"supporting_discovery_ids\": [6, 9, 14, 15, 24, 25]},\n      {\"term_id\": \"R-HSA-74160\", \"supporting_discovery_ids\": [2, 5, 19, 20]},\n      {\"term_id\": \"R-HSA-1640170\", \"supporting_discovery_ids\": [13]}\n    ],\n    \"complexes\": [\n      \"LSD1/CoREST (KDM1A-RCOR-HDAC) complex\",\n      \"INSM1-Neurod1-Foxa2 complex\",\n      \"INSM1-cyclin D1-HDAC repressor complex\"\n    ],\n    \"partners\": [\n      \"CCND1\",\n      \"KDM1A\",\n      \"HDAC1\",\n      \"RCOR1\",\n      \"NEUROD1\",\n      \"FOXA2\",\n      \"RACK1\",\n      \"HDAC3\"\n    ],\n    \"other_free_text\": []\n  }\n}","audit_flag":null,"evaluation":{"pairwise":"win","faith_supported":8,"faith_total":8,"faith_pct":100.0}}